The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Open accessAbstract
The human microbiota has a fundamental role in host physiology and pathology. Gut microbial alteration, also known as dysbiosis, is a condition associated not only with gastrointestinal disorders but also with diseases affecting other distal organs. Recently it became evident that the intestinal bacteria can affect the central nervous system (CNS) physiology and inflammation. The nervous system and the gastrointestinal tract are communicating through a bidirectional network of signaling pathways called the gut-brain axis, which consists of multiple connections, including the vagus nerve, the immune system, and bacterial metabolites and products. During dysbiosis, these pathways are dysregulated and associated with altered permeability of the blood-brain barrier (BBB) and neuroinflammation. However, numerous mechanisms behind the impact of the gut microbiota in neuro-development and -pathogenesis remain poorly understood. There are several immune pathways involved in CNS homeostasis and inflammation. Among those, the inflammasome pathway has been linked to neuroinflammatory conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, but also anxiety and depressive-like disorders. The inflammasome complex assembles upon cell activation due to exposure to microbes, danger signals, or stress and lead to the production of pro-inflammatory cytokines (interleukin-1β and interleukin-18) and to pyroptosis. Evidences suggest that there is a reciprocal influence of microbiota and inflammasome activation in the brain. However, how this influence is precisely working is yet to be discovered. Herein, we discuss the status of the knowledge and the open questions in the field focusing on the function of intestinal microbial metabolites or products on CNS cells during healthy and inflammatory conditions, such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, and also neuropsychiatric disorders. In particular, we focus on the innate inflammasome pathway as immune mechanism that can be involved in several of these conditions, upon exposure to certain microbes.
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes evidence that gut microbiota and microbial metabolites influence CNS physiology and neuroinflammation through the gut-brain axis, with the inflammasome proposed as an innate immune link. It highlights disease-specific findings in multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and neuropsychiatric disorders while emphasizing that causal mechanisms remain largely unresolved.
Key findings
- The gut-brain axis involves the vagus nerve, immune system, bacterial metabolites, and products; dysbiosis is associated with altered blood-brain barrier permeability and neuroinflammation. Germ-free or antibiotic-treated mice show exaggerated HPA stress responses, impaired social behavior, reduced anxiety-like behavior, and increased motor/rearing activity, while SCFAs and tryptophan metabolites can restore microglia maturation, BBB integrity, and immune homeostasis.
- In multiple sclerosis, transplanting MS-twin microbiota into germ-free EAE-susceptible mice promoted disease with significantly higher incidence than healthy-twin microbiota; IL-10–producing Tregs, *B. fragilis* polysaccharide A, SCFAs, and tryptophan-AhR signaling were protective. Inflammasome components caspase-1 and ASC are proposed biomarkers for MS onset, and IL-1β/IL-18/caspase-1 are upregulated in PBMCs and CSF; pertussis toxin–driven pyrin inflammasome IL-1β primes encephalitogenic Th17 cells.
- In Alzheimer’s disease, patients show decreased Firmicutes and Actinobacteria and increased Bacteroidetes; germ-free APP/PS1 mice have reduced Aβ levels and amyloid load, while fecal transplant from conventionally raised APP/PS1 mice increases cerebral Aβ pathology. NLRP3, ASC, caspase-1, IL-1β, and IL-18 are elevated in AD patients, and *Porphyromonas gingivalis* gingipains are found in AD brains and increase Aβ production in mice.
- In Parkinson’s disease, patients harbor depleted SCFA-producing bacteria; germ-free mice colonized with PD patient microbiota display physical impairments, and ASO germ-free mice show reduced α-synuclein aggregates that are restored by SCFA mixture. NLRP3/caspase-1/IL-1β are implicated, and NLRP3−/− mice are resistant to MPTP-induced loss of nigral dopaminergic neurons. In neuropsychiatric disorders, MDD patients have increased Enterobacteriaceae and *Alistipes* but reduced *Faecalibacterium*; schizophrenia patients show 77 differently expressed OTUs; MIA offspring show 67 different OTUs, and the metabolite 4EPS alone induces anxiety-like behavior.
Methods
- Narrative review; no systematic review protocol, search strategy, inclusion/exclusion criteria, or meta-analysis is stated.
- Synthesizes human observational/clinical studies and animal models, including germ-free, SPF, antibiotic-treated, gnotobiotic, transgenic, fecal microbiota transplantation, EAE, APP/PS1, 5xFAD, ASO, and MPTP models, plus in vitro studies.
- Main analysis is qualitative synthesis of mechanisms, with a table summarizing inflammasome-dependent mechanisms in neurological disorders.
Limitations
- The authors state that many mechanisms of microbial action and signaling pathways remain unknown, that causality between dysbiosis and disease is often unclear, and that translational approaches and larger clinical trials are needed to establish temporal and causal relationships.
- The authors note conflicting findings on whether inflammasome deficiency shapes gut microbiota composition, with maternal-microbiota inheritance and cage effects having a more substantial impact in their conditions; they call for additional analyses under specific hygiene conditions.
- Evident from the text: as a narrative review, it lacks a systematic search or quantitative synthesis and relies heavily on animal models and associative human data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 329 cited sources checked · 0 supported · 0 flagged
- Premisenone given
Intestinal bacteria can affect central nervous system physiology and inflammation.
“Recently it became evident that the intestinal bacteria can affect the central nervous system (CNS) physiology and inflammation.”
Quote in the paperSubstantial claim - Premisenone given
There is a reciprocal influence of microbiota and inflammasome activation in the brain.
“Evidences suggest that there is a reciprocal influence of microbiota and inflammasome activation in the brain.”
Quote in the paperNot a substantial claim - Premisecitation
A relevant contribution of gut microbiota is not restricted to neuroinflammatory and psychiatric disorders but also extends to brain development.
“Moreover, a relevant contribution of gut microbiota is not only restricted to neuroinflammatory and psychiatric disorders (23–32) but also to brain development (13).”
Quote in the paperNot a substantial claim0 of 10 sources checked- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- cites [24] Haran, 2019, crossm Alzheimer‘s Disease Microbiome Is Associated with, mBio source
Not checked in the free run.
- cites [25] Chen, 2016, Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls, Sci Rep source
Not checked in the free run.
- cites [26] Inserra, 2018, The Microbiota-Inflammasome Hypothesis of Major Depression, BioEssays source
Not checked in the free run.
- cites [27] Adams, 2011, Gastrointestinal flora and gastrointestinal status in children with autism - comparisons to typical children and correlation with autism severity, BMC Gastroenterol source
Not checked in the free run.
- cites [28] Das, 2015, Dopamine D3 agonists in the treatment of Parkinson’s disease, Curr Top Med Chem source
Not checked in the free run.
- cites [29] Chu, 2019, The microbiota regulate neuronal function and fear extinction learning, Nature source
Not checked in the free run.
- cites [30] Iannone, 2019, Microbiota-gut brain axis involvement in neuropsychiatric disorders, Expert Rev Neurother source
Not checked in the free run.
- cites [31] Burberry, 2020, C9orf72 suppresses systemic and neural inflammation induced by gut microbes, Nature source
Not checked in the free run.
- cites [32] Blacher, 2019, Potential roles of gut microbiome and metabolites in modulating ALS in mice, Nature source
Not checked in the free run.
- Premisenone given
Gut microbial alteration (dysbiosis) is associated not only with gastrointestinal disorders but also with diseases affecting other distal organs, including the central nervous system.
“Gut microbial alteration, also known as dysbiosis, is a condition associated not only with gastrointestinal disorders but also with diseases affecting other distal organs.”
Quote in the paperSubstantial claim - Premisecitation
Neuronal development is supported and shaped by maternal microbiota.
“In this period, neuronal development takes place (73) and it is supported and shaped by maternal microbiota (74–79).”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [73] O’Mahony, 2017, Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle, Neuroscience source
Not checked in the free run.
- cites [74] De Palma, 2015, Microbiota and host determinants of behavioural phenotype in maternally separated mice, Nat Commun source
Not checked in the free run.
- cites [75] De Agüero, 2016, The maternal microbiota drives early postnatal innate immune development, Science (80-) source
Not checked in the free run.
- cites [76] Sarker, 2019, Maternal overnutrition induces long-term cognitive deficits across several generations, Nutrients source
Not checked in the free run.
- cites [77] Fleshner, 2017, Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders, Neuropsychopharmacology source
Not checked in the free run.
- cites [78] Pasciuto, 2020, Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition, Cell source
Not checked in the free run.
- cites [79] Vuong, 2020, The maternal microbiome modulates fetal neurodevelopment in mice, Nature source
Not checked in the free run.
- Premisecitation
Early experiments using germ-free or specific pathogen-free mice treated with antibiotics to reduce microbial diversity showed that several neurological problems occur in mice with reduced or lack of proper mature gut microbiota.
“Early experiments using germ-free (GF) or specific pathogen-free (SPF) mice treated with antibiotics, to reduce the microbial diversity within the intestine, showed that several neurological problems occur in mice with reduced or lack of proper mature gut microbiota (7, 10, 14, 15, 34, 80, 81).”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [7] Clarke, 2013, The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Mol Psychiatry source
Not checked in the free run.
- cites [10] Sudo, 2004, Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice, J Physiol source
Not checked in the free run.
- cites [14] De Vadder, 2014, Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits, Cell source
Not checked in the free run.
- cites [15] Buffington, 2016, Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring, Cell source
Not checked in the free run.
- cites [34] Daneman, 2015, The blood-brain barrier, Cold Spring Harb Perspect Biol source
Not checked in the free run.
- cites [80] Heijtz, 2011, Normal gut microbiota modulates brain development and behavior, Proc Natl Acad Sci U S A source
Not checked in the free run.
- cites [81] Neufeld, 2011, Reduced anxiety-like behavior and central neurochemical change in germ-free mice, Neurogastroenterol Motil source
Not checked in the free run.
- Premisecitation
Neurotransmitters such as acetylcholine, GABA, and serotonin produced by bacteria belonging to Lactobacillus, Bifidobacteria, Enterococcus, and Streptococcus species can influence brain cell physiology directly and indirectly.
“Neurotransmitters, such as acetylcholine, GABA, and serotonin, produced by bacteria belonging to Lactobacillus, Bifidobacteria, Enterococcus, and Streptococcus species, can influence brain cell physiology directly and indirectly (11, 85, 86).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [11] Yano, 2015, Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis, Cell source
Not checked in the free run.
- cites [85] Pokusaeva, 2017, GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine, Neurogastroenterol Motil source
Not checked in the free run.
- cites [86] Komatsuzaki, 2005, Rapid spinogenesis of pyramidal neurons induced by activation of glucocorticoid receptors in adult male rat hippocampus, Biochem Biophys Res Commun source
Not checked in the free run.
- Premisecitation
The altered behavioral phenotype after antibiotic treatment is associated with dysregulation of genes and metabolites known to be involved in motor control and anxiety-like behavior pathways, including adrenaline, dopamine, 5-HT, PSD-95, and synaptophysin.
“The altered behavioral phenotype was associated with dysregulation of genes and metabolites known to be involved in motor control and anxiety-like behavior pathways, like adrenaline, dopamine, 5-hydroxytryptophan (5-HT), postsynaptic density protein 95 (PSD-95), and synaptophysin (80).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Heijtz, 2011, Normal gut microbiota modulates brain development and behavior, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
90% of serotonin required for mood, behavior, sleep, and several other functions within the CNS and gastrointestinal tract is produced in the gut.
“Strikingly, 90% of serotonin required for mood, behavior, sleep, and several other functions within the CNS and gastrointestinal (GI) tract is produced in the gut (87).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [87] Gershon, 2013, 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract, Curr Opin Endocrinol Diabetes Obes source
Not checked in the free run.
- Premisecitation
Certain altered brain developments and behaviors observed in germ-free mice can be resolved or improved when newborn animals are reconstituted with a diverse and intact flora.
“Consistently, certain altered brain developments and behaviors observed in GF mice could be resolved/improved when new born animals were reconstituted with a diverse and intact flora (73, 82, 83).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [73] O’Mahony, 2017, Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle, Neuroscience source
Not checked in the free run.
- cites [82] Cryan, 2012, Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour, Nat Rev Neurosci source
Not checked in the free run.
- cites [83] Cryan, 2019, The microbiota-gut-brain axis, Physiol Rev source
Not checked in the free run.
- Premisecitation
Microbes can produce neuroactive molecules that directly contribute to communication between the gut and the brain.
“Lately, it is becoming more evident that microbes can produce neuroactive molecules that directly contribute to the communication between the gut and the brain ( Figure 1 ).”
Quote in the paperSubstantial claim - Premisecitation
Binding of serotonin to 5-HT receptors on microglia induces the release of cytokine-carrying exosomes, providing a mechanism for gut-induced modulation of neuroinflammation.
“Binding of serotonin to 5-HT receptors on microglia induces the release of cytokine-carrying exosomes, providing another mechanism for gut-induced modulation of neuroinflammation (88).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Glebov, 2015, Serotonin stimulates secretion of exosomes from microglia cells, Glia source
Not checked in the free run.
- Premisecitation
Tryptophan, a serotonin precursor, influences microglia activity.
“Another microbial metabolite that influences microglia activity is tryptophan, a serotonin precursor (89).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
- Interpretationcitation
The systemic circulation could be the route through which the microbiota influences CNS serotonergic neurotransmission.
“These findings suggest that the systemic circulation could be the route through which the microbiota influences CNS serotonergic neurotransmission.”
Quote in the paperSubstantial claim - Premisecitation
Male germ-free animals have significantly higher levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the hippocampus and serum compared with conventionally colonized control animals.
“The importance of tryptophan metabolism in maintaining CNS homeostasis was already known a few years earlier, since male GF animals have significantly higher levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the hippocampus and the serum, compared with conventionally colonized control animals (7).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Clarke, 2013, The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Mol Psychiatry source
Not checked in the free run.
- Premisecitation
Bacterial metabolites derived from dietary tryptophan can control CNS inflammation through an aryl hydrocarbon receptor-mediated mechanism acting on microglial activation and the transcriptional program of astrocytes.
“Bacterial metabolites derived from dietary tryptophan could control the CNS inflammation through an aryl hydrocarbon receptor (Ahr)-mediated mechanism acting on microglial activation and the transcriptional program of astrocytes (89).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
- Premisecitation
Germ-free mice, SPF mice treated with antibiotics, or gnotobiotic mice with limited microbiome diversity show impaired microglia maturation and immune response upon bacterial stimuli compared to SPF mice.
“From an immunological and metabolomic point of view, GF, SPF mice treated with antibiotics, or gnotobiotic mice with limited microbiome diversity (colonized with ASF for example) showed impaired microglia maturation and immune response upon bacterial stimuli, compared to SPF mice (94).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [94] Erny, 2017, Host microbiota constantly control maturation and function of microglia in the CNS, Nat Neurosci source
Not checked in the free run.
- Premisecitation
SPF mice treated with broad-spectrum antibiotics, germ-free mice, and germ-free mice recolonized after weaning with a simple or complex microbiota have defects in fear extinction learning compared to SPF mice or germ-free mice colonized with SPF flora at birth.
“In 2019, Artis D.’s group showed that SPF mice treated with a cocktail of broad-spectrum antibiotics, GF mice, GF mice recolonized after weaning age with a simple microbiota or a complex microbiota, have defects in fear extinction learning, compared to SPF mice or GF mice colonized with SPF flora at the time of birth (29).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Chu, 2019, The microbiota regulate neuronal function and fear extinction learning, Nature source
Not checked in the free run.
- Premisecitation
Probiotic supplementation with Lactobacillus rhamnosus (JB-1) in already colonized mice reduced anxiety- and depression-like behavior in steady-state conditions.
“Furthermore, probiotic supplementations, as Lactobacillus rhamnosus (JB-1), in already colonized mice, reduced anxiety- and depression-like behavior in steady-state conditions (92, 93).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [92] Reis, 2018, The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature, PloS One source
Not checked in the free run.
- cites [93] McVey Neufeld, 2018, Mouse Strain Affects Behavioral and Neuroendocrine Stress Responses Following Administration of Probiotic Lactobacillus rhamnosus JB-1 or Traditional Antidepressant Fluoxetine, Front Neurosci source
Not checked in the free run.
- Premisecitation
The microbiota-mediated changes in synapse formation and fear extinction behavior were not results of the hypothalamic-pituitary-adrenal axis but of reduced levels of potential neuroactive metabolites (phenyl sulfate, pyrocatechol sulfate, 3-(3-sulfooxyphenyl)propanoic acid, and indoxyl sulfate) in cerebrospinal fluid, serum, and fecal samples of germ-free mice compared to SPF mice.
“The researchers showed that the microbiota-mediated changes in synapse formation and fear extinction behavior were not the results of the hypothalamic-pituitary-adrenal axis but of the reduced level of potential neuroactive metabolites (phenyl sulfate, pyrocatechol sulfate, 3-(3-sulfooxyphenyl)propanoic acid, and indoxyl sulfate) in the cerebrospinal fluid, serum and in fecal samples of GF mice”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Chu, 2019, The microbiota regulate neuronal function and fear extinction learning, Nature source
Not checked in the free run.
- Premisecitation
Treating germ-free mice with oral application of a mixture of the three major short-chain fatty acids acetate, propionate, and butyrate was sufficient to restore the normal maturation process of microglia.
“Remarkably, treating GF mice with the oral application of a mixture of the three major SCFAs acetate, propionate, and butyrate, was also sufficient to restore the normal maturation process of the microglia (94).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Erny, 2017, Host microbiota constantly control maturation and function of microglia in the CNS, Nat Neurosci source
Not checked in the free run.
- Premisecitation
Short-chain fatty acids are detectable in low amounts in the human brain under physiological conditions.
“SCFAs are, in fact, detectable in low amounts in the human brain under physiological conditions (102).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Wishart, 2018, HMDB 4.0: the human metabolome database for 2018, Nucleic Acids Res source
Not checked in the free run.
- Premisecitation
Colonization of adult germ-free mice with a complex microbiota or only with short-chain fatty acid-producing bacterial strains restores the integrity of the blood-brain barrier.
“Additionally, they also affect the BBB itself; the colonization of adult GF mice with a complex microbiota or only with SCFAs-producing bacterial strains restores the integrity of the BBB (91).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Braniste, 2014, The gut microbiota influences blood-brain barrier permeability in mice, Sci Transl Med source
Not checked in the free run.
- Premisecitation
Bacterial fermentation of indigestible dietary fibers produces the short-chain fatty acids butyrate, propionate, and acetate in the colon.
“In addition, bacterial fermentation of indigestible dietary fibers produces among the SCFAs, butyrate, propionate, and acetate in the colon (97).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [97] Cummings, 1987, Fermentation in the human large intestine and the available substrates, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
The microbiota composition differs significantly between healthy controls and patients affected by neurodegenerative disorders such as multiple sclerosis, Alzheimer's and Parkinson's diseases, and neuropsychiatric disorders.
“The microbiota composition differs significantly between healthy controls and patients affected by neurodegenerative disorders (such as multiple sclerosis (MS), Alzheimer’s (AD) and Parkinson’s (PD) diseases) (20, 22, 23, 32, 111–115), and neuropsychiatric disorders (NPS) (30), like major depressive and mood disorders.”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [20] Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell source
Not checked in the free run.
- cites [22] Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol source
Not checked in the free run.
- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- cites [32] Blacher, 2019, Potential roles of gut microbiome and metabolites in modulating ALS in mice, Nature source
Not checked in the free run.
- cites [111] Sampson, 2016, Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease, Cell source
Not checked in the free run.
- cites [112] Berer, 2017, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [113] Sharon, 2019, Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice, Cell source
Not checked in the free run.
- cites [114] Cenit, 2017, Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition, Eur Child Adolesc Psychiatry source
Not checked in the free run.
- cites [115] Hughes, 2018, The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders, Curr Neurol Neurosci Rep source
Not checked in the free run.
- cites [30] Iannone, 2019, Microbiota-gut brain axis involvement in neuropsychiatric disorders, Expert Rev Neurother source
Not checked in the free run.
- Premisecitation
Short-chain fatty acids can modulate neurotransmitters such as glutamate, glutamine, GABA, and neurotrophic factors.
“Moreover, SCFAs can modulate neurotransmitters, like glutamate, glutamine, GABA, and neurotrophic factors (103).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
- Premisecitation
Among environmental factors, microbes and their secreted products or toxins play a critical role in the pathogenesis of multiple sclerosis.
“Among the environmental factors, microbes (and their secreted products or toxins) play a critical role in the pathogenesis of MS (132, 133).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The altered microbiota of patients could transfer the disease from a human host to a mouse host.
“Of extreme relevance, the altered microbiota of patients could transfer the disease from a human host to a mouse host (113, 116–120).”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [113] Sharon, 2019, Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice, Cell source
Not checked in the free run.
- cites [116] Ochoa-Repáraz, 2010, Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression, J Immunol source
Not checked in the free run.
- cites [117] Kyung, 2011, Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis, PNAS source
Not checked in the free run.
- cites [118] Rothhammer, 2016, Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the hydrocarbon receptor, Nat Med source
Not checked in the free run.
- cites [119] Agus, 2018, Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease, Cell Host Microbe source
Not checked in the free run.
- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
- Premisecitation
The microbiota composition of multiple sclerosis patients is different from that of healthy individuals.
“First of all, the microbiota composition of MS patients is different from the one of healthy individuals (104).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104] Oleskin, 2016, Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota, Microb Ecol Health Dis source
Not checked in the free run.
- Premisecitation
Bacteria belonging to the Clostridia family contribute to the suppression of pathological autoimmunity.
“Bacteria belonging to the Clostridia family contribute to the suppression of pathological autoimmunity (134, 139–143).”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [134] Miyake, 2015, Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters, PLos One source
Not checked in the free run.
- cites [139] Atarashi, 2013, Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota, Nature source
Not checked in the free run.
- cites [140] Geuking, 2011, Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses, Immunity source
Not checked in the free run.
- cites [141] Atarashi, 2011, Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species, Science (80-) source
Not checked in the free run.
- cites [142] Jia, 2017, Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice, Sci Rep source
Not checked in the free run.
- cites [143] Chen, 2019, Gut Microbiota Interventions With Clostridium butyricum and Norfloxacin Modulate Immune Response in Experimental Autoimmune Encephalomyelitis Mice, Front Immunol source
Not checked in the free run.
- Premisecitation
Multiple sclerosis twins had a higher abundance of taxa like Akkermansia in their feces.
“They reported that MS-twins had a higher abundance of taxa like Akkermansia in their feces (112).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] Berer, 2017, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
Higher abundance of Firmicutes and absence of Fusobacteria were associated with a shorter time to relapse in pediatric multiple sclerosis patients.
“Higher abundance of Firmicutes and the absence of Fusobacteria were associated with a shorter time to relapse in pediatric MS patients (144).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [144] Tremlett, 2017, The gut microbiome in human neurological disease: A review, Ann Neurol source
Not checked in the free run.
- Premisecitation
Transplanting multiple sclerosis twins' intestinal microbes into germ-free animals genetically susceptible to experimental autoimmune encephalomyelitis promoted the disease in vivo with significantly higher incidence than transplanting healthy twins' microbes.
“However, the remarkable finding was that transplanting the MS-twins’ intestinal microbes into GF animals, genetically susceptible to developing experimental autoimmune encephalomyelitis (EAE) was enough to promote the disease in vivo with a significantly higher incidence than by transplanting the healthy twins’ microbes (112).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Berer, 2017, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci USA source
Not checked in the free run.
- Interpretationcitation
The human microbiota has the potential to induce specific immune system alterations that might be the cause or the effect of the development of multiple sclerosis.
“This significant finding highlighted the potential of the human microbiota to induce specific immune system alterations that might be the cause or the effect of the development of MS.”
Quote in the paperSubstantial claim - Premisecitation
Immune cells of murine recipients of multiple sclerosis-derived samples produced less IL-10 than cells from mice colonized with microbiota derived from healthy twins.
“Interestingly, the immune cells of murine recipients of MS-derived samples produced less IL-10 than cells from mice colonized with the microbiota derived from the healthy twins (112).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Berer, 2017, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
Neutralization of IL-10 in mice colonized with healthy fecal samples increased disease incidence.
“IL-10 is one of the master regulatory cytokines, and its neutralization in mice colonized with healthy fecal samples increased disease incidence (112).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Berer, 2017, Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci USA source
Not checked in the free run.
- Premisecitation
Oral but not systemic treatment with broad-spectrum antibiotics (ampicillin, vancomycin, neomycin, and metronidazole) ameliorated the development of acute experimental autoimmune encephalomyelitis in two mouse models on C57BL/6 and SJL backgrounds.
“Kasper L.’s group showed that oral but not systemic treatment with a classical pool of broad-spectrum antibiotics (ampicillin, vancomycin, neomycin, and metronidazole) ameliorated the development of acute EAE, in two mouse models (on C57BL/6 and SJL backgrounds) (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Ochoa-Repáraz, 2009, Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis, J Immunol source
Not checked in the free run.
- Premisecitation
B. fragilis induced experimental autoimmune encephalomyelitis protection through the generation of IL-10-producing T regulatory cells in a PSA-dependent manner.
“The authors also understood that B. fragilis induced EAE protection through the generation of IL-10–producing T regulatory (Treg) cells in a PSA-dependent manner (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell source
Not checked in the free run.
- Premisecitation
Germ-free mice were almost completely protected from experimental autoimmune encephalomyelitis compared to conventionally colonized mice.
“Thereafter, Lee Y. and colleagues showed for the first time that GF mice were almost completely protected from EAE compared to conventionally colonized mice (117).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Kyung, 2011, Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis, PNAS source
Not checked in the free run.
- Premisecitation
Oral treatment with PSA could cause protection from experimental autoimmune encephalomyelitis in mice, when used as both prophylactic and therapeutic approach, via recruitment of CD103+ CD11chigh antigen-presenting cells and priming of IL-10-producing Treg cells in the cervical lymph nodes.
“They then concluded that oral treatment with PSA could cause protection from EAE in mice, when used as both prophylactic and therapeutic approach, via recruitment of CD103+ CD11chigh antigen-presenting cells and priming of IL-10–producing Treg cells in the cervical lymph-nodes (150).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150] Ochoa-Repáraz, 2010, A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease, Mucosal Immunol source
Not checked in the free run.
- Premisecitation
Better disease outcome upon oral antibiotic treatment was associated with a reduction of pro-inflammatory cytokines and an increase in regulatory cytokines like IL-10.
“The better disease outcome upon oral antibiotic treatment was associated with a reduction of pro-inflammatory cytokines and an increase in regulatory cytokines like IL-10 (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Ochoa-Repáraz, 2009, Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis, J Immunol source
Not checked in the free run.
- Premisecitation
Microbial specific IgA-secreting cells are present in both the bone marrow and the brain of experimental autoimmune encephalomyelitis-affected mice but not in healthy animals.
“Microbial specific IgA-secreting cells were shown to be present in both the bone marrow and, in particular, in the brain of EAE-affected mice but not in healthy animals.”
Quote in the paperSubstantial claim - Premisecitation
Protection from experimental autoimmune encephalomyelitis in germ-free mice was associated with a decrease of pro-inflammatory cytokine levels such as IFN-γ and IL-17A and an increase in Treg cells in the peripheral organs, gut, and spinal cord.
“Again, the protection was associated with a decrease of pro-inflammatory cytokine levels, such as IFN-γ and IL-17A, and an increase in Treg cells in the peripheral organs, the gut and the spinal cord (117).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Kyung, 2011, Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis, PNAS source
Not checked in the free run.
- Premisecitation
In vivo treatment with ampicillin induced complete depletion of Allobaculum bacteria from the small bowel.
“Miyauchi E. and colleagues showed that the in vivo treatment with ampicillin induced the complete depletion of Allobaculum bacteria from the small bowel.”
Quote in the paperSubstantial claim - Premisecitation
Mice bearing a T cell receptor specific for myelin-oligodendrocyte glycoprotein (2D2 mice) showed a higher number of CD4+ T cells in the small intestinal lamina propria compared to their wild-type counterpart.
“Mice bearing a T cell-receptor (TCR) specific for myelin-oligodendrocyte glycoprotein (MOG) (2D2 mice) showed higher number of CD4+ T cells in the small intestinal lamina propria compared to their wild-type counterpart (152).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [152] Miyauchi, 2020, Gut microorganisms act together to exacerbate inflammation in spinal cords, Nature source
Not checked in the free run.
- Premisecitation
L. reuteri monocolonization did not affect the severity of experimental autoimmune encephalomyelitis.
“Interestingly, L. reuteri monocolonization did not affect the severity of EAE.”
Quote in the paperSubstantial claim - Interpretationcitation
Certain intestinal bacterial species profoundly affect experimental autoimmune encephalomyelitis pathogenesis, altering the balance between pro- and anti-inflammatory immune responses via a direct effect of some bacterial products.
“Altogether, these breakthrough murine studies prove that certain intestinal bacterial species profoundly affect EAE pathogenesis, altering the balance between pro- and anti-inflammatory immune responses via a direct effect of some bacterial products.”
Quote in the paperSubstantial claim - Premisecitation
Antibiotic treatment after the onset of the first signs of spontaneous experimental autoimmune encephalomyelitis did not affect the ongoing disease and CNS inflammation.
“In contrast, antibiotic treatment after the onset of the first signs of spontaneous EAE did not affect the ongoing disease and CNS inflammation (153).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] Gödel, 2020, Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease, J Neuroinflammation source
Not checked in the free run.
- Interpretationreasoning
Only certain bacteria with specific metabolic or structural characteristics appear effective in preventing or postponing the onset of certain conditions.
“Notably, only certain bacteria with specific metabolic or structural characteristics appear effective in preventing or postponing the onset of certain conditions.”
Quote in the paperSubstantial claim - Premisecitation
Treating mice with antibiotics or feeding them a tryptophan-deficient diet during the recovery phase of experimental autoimmune encephalomyelitis worsened the experimental autoimmune encephalomyelitis scores.
“Firstly, they showed that treating mice with antibiotics or feeding them with a Trp-deficient diet during the recovery phase of the EAE model worsened the EAE scores (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] Rothhammer, 2016, Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the hydrocarbon receptor, Nat Med source
Not checked in the free run.
- Premisecitation
The gut microbiota metabolizes dietary tryptophan into aryl hydrocarbon receptor agonists.
“The gut microbiota metabolizes dietary tryptophan into AhR agonists (119).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [119] Agus, 2018, Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease, Cell Host Microbe source
Not checked in the free run.
- Premisecitation
Oral administration of short-chain fatty acids ameliorates experimental autoimmune encephalomyelitis development and disease severity.
“Such as, oral administration of SCFAs ameliorate EAE development and disease severity (155, 156).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [155] Haghikia, 2015, System Autoimmunity via the Small Intestine Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine, Immunity source
Not checked in the free run.
- cites [156] Mizuno, 2017, The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models, PLOS One source
Not checked in the free run.
- Interpretationcitation
Aryl hydrocarbon receptor agonists act via a direct effect on astrocytes to limit CNS inflammation during experimental autoimmune encephalomyelitis.
“In conclusion, they suggested a mode of action of Ahr agonists, via a direct effect on astrocytes to limit CNS inflammation during EAE (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] Rothhammer, 2016, Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the hydrocarbon receptor, Nat Med source
Not checked in the free run.
- Premisecitation
Tryptophan or indoxyl-3-sulfate treatment ameliorated experimental autoimmune encephalomyelitis scores in control mice but not in mice lacking AhR expression on microglia fed a tryptophan-deficient diet.
“Briefly, Trp or I3S treatment ameliorated EAE scores in control mice but not in mice lacking AhR expression on the microglia fed with Trp-deficient diet (89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
- Premisecitation
In multiple sclerosis patients, circulating levels of aryl hydrocarbon receptor agonists are decreased.
“They also found that in patients affected by MS, the circulating levels of AhR agonists are decreased.”
Quote in the paperSubstantial claim - Premisecitation
Microglia have a crucial role in the mechanism of protection from experimental autoimmune encephalomyelitis via the tryptophan-AhR pathway.
“A couple of years later, the same group discovered that the microglia has a crucial role in this mechanism of protection from EAE via the Trp-AhR pathway (89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
- Premisecitation
AhR, TGF-α, and VEGF-β expression were detected on myeloid CD14+ cells in demyelinated active and chronic multiple sclerosis lesions of patients.
“Finally, they detected AhR, TGF-α, and VEGF-β expression on myeloid CD14+ cells in the demyelinated active and chronic MS lesions of patients (89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
- Interpretationcitation
Metabolites derived from digestion of tryptophan by the gut flora activate AhR signaling in astrocytes and microglia and induce immune protection mechanisms important to suppress CNS inflammation, in animal models and perhaps also in human patients.
“These findings suggest that metabolites derived from the digestion of tryptophan by the gut flora activate AhR signaling in astrocytes and microglia and induce immune protection mechanisms in the host that are important to suppress CNS inflammation, in both animal models and perhaps also in human patients.”
Quote in the paperSubstantial claim - Interpretationreasoning
Different interventions aimed to modify the microbiota composition have efficacy as prophylactic or therapeutic approaches.
“Altogether, these works suggest the efficacy of different interventions aimed to modify the microbiota composition as prophylactic or therapeutic approaches.”
Quote in the paperSubstantial claim - Premisecitation
Stool microbial profile of Alzheimer's disease patients displays decreased numbers of Firmicutes and Actinobacteria and increased Bacteroidetes compared to controls.
“Stool microbial profile of AD patients display decreased numbers of Firmicutes and Actinobacteria, and increased Bacteroidetes compared to controls.”
Quote in the paperNot a substantial claim - Premisecitation
Treatment initiated 14 days after experimental autoimmune encephalomyelitis induction ameliorated the disease via AhR engagement on astrocytes and microglia.
“This treatment was initiated 14 days after EAE induction and ameliorated the disease via AhR engagement on astrocytes and microglia (89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
- Premisecitation
APP/PS1 double transgenic mice show a remarkable shift in gut microbiota composition compared to healthy wild-type mice.
“APP/PS1 double transgenic mice, which express special neurons in the CNS with a chimeric mouse/human amyloid precursor protein (APP) and a mutant human presenilin 1 (PS1), show a remarkable shift in the gut microbiota composition compared to healthy wild-type mice (161).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Harach, 2017, Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Sci Rep source
Not checked in the free run.
- Premisecitation
Within the Firmicutes, the families Ruminococcaceae, Turicibacteraceae, and Clostridiaceae were all less abundant in Alzheimer's disease patients.
“Within the Firmicutes, the families Ruminococcaceae, Turicibacteraceae, and Clostridiaceae were all less abundant in AD patient (160).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Vogt, 2017, Gut microbiome alterations in Alzheimer‘s disease, Sci Rep source
Not checked in the free run.
- Premisecitation
Fecal transplantation from conventionally-raised APP/PS1 mice into germ-free APP/PS1 hosts dramatically increased cerebral Aβ pathology in the hosts.
“Fecal transplantation from conventionally-raised APP/PS1 mice into GF APP/PS1 hosts dramatically increased cerebral Aβ pathology in the hosts (161).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Harach, 2017, Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Sci Rep source
Not checked in the free run.
- Premisecitation
Fewer Firmicutes (Akkermansia and Rikenellaceaea) but more Bacteroidetes (S24-7) were identified in conventionally-raised APP/PS1 mice compared to wild-type littermate controls.
“Fewer Firmicutes (Akkermansia and Rikenellaceaea) but more Bacteroidetes (S24-7) were identified in conventionally-raised APP/PS1 mice compared to wild-type littermate controls (161).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Harach, 2017, Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Sci Rep source
Not checked in the free run.
- Interpretationcitation
These results strongly supported a microbiota involvement in the development of Alzheimer's disease in Alzheimer's disease-susceptible animal models.
“Altogether, these results strongly supported a microbiota involvement in the development of AD in AD-susceptible animal models (161).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Harach, 2017, Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Sci Rep source
Not checked in the free run.
- Premisecitation
Anti-inflammatory microglia declined from three to five months and maintained at low levels after that.
“On the other hand, the anti-inflammatory microglia declined from three to five months and maintained at low levels after that.”
Quote in the paperSubstantial claim - Interpretationreasoning
Changes in microbiota composition have been monitored during a neurological disease development, suggesting that bacterial changes could be happening together with or before the immunological and neurological changes.
“Importantly, this was the first time that changes in the microbiota composition have been monitored during a neurological disease development suggesting that the bacterial changes could be happening together or before the immunological and neurological changes.”
Quote in the paperSubstantial claim - Premisecitation
Changes in microbiota composition were associated with neuroinflammatory markers.
“These changes in microbiota composition were associated with neuroinflammatory markers.”
Quote in the paperSubstantial claim - Premisecitation
At the age of two-three months, when Aβ plaque deposition in the cortex and hippocampus starts, Bacteroides, Firmicutes, and Verrucomicrobia were the most abundant bacterial phyla.
“At the age of two–three months, when Aβ plaque deposition in the cortex and hippocampus starts, Bacteroides, Firmicutes, and Verrucomicrobia were the most abundant bacterial phyla (163).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
- Premisecitation
Co-housing or FMT experiments showed that neuroinflammation and cognitive impairments could be transferred from 5xFAD mice to wild-type counterparts.
“Co-housing or FMT experiments showed that neuroinflammation and cognitive impairments could be transferred from 5xFAD mice to wild-type counterparts (163).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
- Premisecitation
Metabolomic analyses on feces of these animals revealed significant changes in amino acid-related metabolism, particularly phenylalanine- and isoleucine-related pathways.
“Metabolomic analyses on the feces of these animals revealed significant changes in amino acid–related metabolism, in particular for the phenylalanine- and isoleucine-related pathways.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
- Premisecitation
Phenylalanine and isoleucine can be taken up by adaptive immune cells such as Th-1 cells.
“Phenylalanine and isoleucine can be uptaken by adaptive immune cells, like Th-1 cells (163).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
- Premisecitation
ADLPAPT mice present community-level alterations in microbiota compared to wild-type animals.
“Similarly, a recent work showed that ADLPAPT mice present community level-alterations in the microbiota compared to wild-type animals (166).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [166] Kim, 2020, Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model, Gut source
Not checked in the free run.
- Premisecitation
ADLPAPT mice develop an AD-like pathology with amyloid and neurofibrillary tangles.
“The ADLPAPT mice carry six human mutations affecting amyloid precursor protein, presenilin-1, and tau protein, and develop an AD-like pathology with amyloid and neurofibrillary tangles (167).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [167] Kim, 2018, Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics, Mol Neurodegener source
Not checked in the free run.
- Premisecitation
ADLPAPT mice carry six human mutations affecting amyloid precursor protein, presenilin-1, and tau protein.
“The ADLPAPT mice carry six human mutations affecting amyloid precursor protein, presenilin-1, and tau protein, and develop an AD-like pathology with amyloid and neurofibrillary tangles (167).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [167] Kim, 2018, Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics, Mol Neurodegener source
Not checked in the free run.
- Premisecitation
Oral Bifidobacterium longum NK46 in 5xFAD mice induced anti-inflammatory effects, including decreased LPS levels, NF-κB activation, and TNF-α expression.
“The human isolate Bifidobacterium longum (NK46) was orally administered in 5xFAD mice and induced anti-inflammatory effects (decrease in lipopolysaccharide (LPS) levels, NF-κB activation, and TNF-α expression), changes in the intestinal microbiota composition of the recipients (increase in Bacteroides and reduction in Firmicutes and Proteobacteria phyla), and suppression of Aβ accumulation in the”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170] Lee, 2019, Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice, Sci Rep source
Not checked in the free run.
- Interpretationreasoning
Gut microbes promote neuroinflammation in AD progression through alterations in metabolic and immunological pathways.
“Together, these findings highlight the role of gut microbes in the promotion of neuroinflammation in AD progression through alteration in metabolic and immunological pathways.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Rests on an assumption: The composition and function of the gut microbiota in mice and humans are sufficiently similar for mouse FMT or colonization results to inform human disease mechanisms.
- Premisecitation
P. gingivalis 16S rRNA was detected in both the cerebrospinal fluid and the cerebral cortex of AD patients.
“P. gingivalis 16S rRNA was detected in both the cerebrospinal fluid and in the cerebral cortex of AD patients (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
- Interpretationcitation
Porphyromonas gingivalis, the causing agent of chronic periodontitis, has a role in the etiology of AD.
“To conclude, an intriguing and relevant role of the oral pathogen Porphyromonas gingivalis, the causing agent of chronic periodontitis, has been elucidated in the etiology of AD (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Premisecitation
Oral Bifidobacterium longum NK46 in 5xFAD mice suppressed Aβ accumulation in the hippocampus.
“The human isolate Bifidobacterium longum (NK46) was orally administered in 5xFAD mice and induced anti-inflammatory effects (decrease in lipopolysaccharide (LPS) levels, NF-κB activation, and TNF-α expression), changes in the intestinal microbiota composition of the recipients (increase in Bacteroides and reduction in Firmicutes and Proteobacteria phyla), and suppression of Aβ accumulation in the”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170] Lee, 2019, Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice, Sci Rep source
Not checked in the free run.
- Premisecitation
Porphyromonas gingivalis and gingipains were identified in the brain of AD patients but not in the brain of control patients with no history of neurological abnormality or condition.
“Dominy SS. and colleagues identified Porphyromonas gingivalis and the gingipains, the toxic proteases produced by this bacterium, in the brain of AD patients but not in the brain of control patients with no history of any neurological abnormality or condition (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
- Premisecitation
Gingipains co-localized with neurons, astrocytes, tau tangles, and intraneuronal Aβ in AD patient tissue.
“Gingipains co-localized with neurons and astrocytes and also tau tangles and intraneuronal Aβ in the tissue of AD patients (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
- Premisecitation
PD patients have a different microbiota composition compared to healthy controls or patients affected by other neurological disorders.
“As with most of the diseases, PD patients have a different microbiota composition compared to healthy controls or patients affected by other neurological disorders (174–176).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [174] Hasegawa, 2015, Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease, PloS One source
Not checked in the free run.
- cites [175] Keshavarzian, 2015, Colonic bacterial composition in Parkinson’s disease, Mov Disord source
Not checked in the free run.
- cites [176] Scheperjans, 2015, Gut microbiota are related to Parkinson’s disease and clinical phenotype, Mov Disord source
Not checked in the free run.
- Premisecitation
PD patients harbor an intestinal flora depleted in SCFA (mainly butyrate)-producing bacteria, including taxa from Lachnospiraceae and Faecalibacterium prausnitzii, which have known anti-inflammatory properties.
“Remarkably, PD patients harbored an intestinal flora depleted in SCFAs (mainly butyrate)-producing bacteria, like taxa from Lachnospiraceae family (175, 177–179), and Faecalibacterium prausnitzii (175, 180), those with known anti-inflammatory properties.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [175] Keshavarzian, 2015, Colonic bacterial composition in Parkinson’s disease, Mov Disord source
Not checked in the free run.
- cites [177] Hill-Burns, 2017, Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome, Mov Disord source
Not checked in the free run.
- cites [178] Barichella, 2019, Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism, Mov Disord source
Not checked in the free run.
- cites [179] Petrov, 2017, Analysis of Gut Microbiota in Patients with Parkinson’s Disease, Bull Exp Biol Med source
Not checked in the free run.
- cites [180] Unger, 2016, Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls, Parkinsonism Relat Disord source
Not checked in the free run.
- Premisecitation
Oral P. gingivalis infection in mice not genetically susceptible to AD resulted in detection of P. gingivalis DNA in the brain and remarkably increased production of Aβ deposits.
“The oral P. gingivalis infection in mice that are not genetically susceptible to develop AD resulted in the detection of P. gingivalis DNA in the brain and remarkably increased production of Aβ deposits (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
- Premisecitation
GF mice colonized with microbiota from PD patients display physical impairments compared to GF mice colonized with microbiota from healthy human donors.
“GF mice colonized with microbiota from PD patients display physical impairments compared to GF mice colonized with microbiota from healthy human donors (111).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [111] Sampson, 2016, Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease, Cell source
Not checked in the free run.
- Interpretationcitation
The microbiota has an essential role in PD pathogenesis in animal models.
“An essential role of the microbiota in PD pathogenesis has been shown in animal models.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Rests on an assumption: The composition and function of the gut microbiota in mice and humans are sufficiently similar for mouse FMT or colonization results to inform human disease mechanisms.
- Premisecitation
Host exposure to dead bacteria was not sufficient to induce pathogenesis in ASO-GF mice.
“Host exposure to dead bacteria was not sufficient to induce the pathogenesis in the ASO-GF mice (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
- Premisecitation
Antibiotic treatment of SPF ASO mice induced very mild α-syn-dependent motor dysfunction, like in mice born under GF conditions.
“Antibiotic treatment of SPF ASO mice induced very mild α-syn-dependent motor dysfunction, like in mice born under GF conditions (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
- Premisecitation
Colonization of ASO GF animals with SPF flora at five-six weeks of age recapitulated the significant motor dysfunction observed in ASO SPF mice.
“Moreover, colonization of ASO GF animals with SPF flora at five-six weeks of age recapitulated the significant motor dysfunction observed in ASO SPF mice (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
- Premisecitation
Differences in microbiome profile, SCFA amount, and motor dysfunctions (increase in propionate and butyrate) were transferred and maintained in vivo in GF mice receiving PD patient-derived feces.
“The differences in the microbiome profile, in SCFAs amount, and motor dysfunctions (increase in propionate and butyrate) were transferred and maintained in vivo too (111).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [111] Sampson, 2016, Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease, Cell source
Not checked in the free run.
- Interpretationreasoning
The same bacterial metabolite could have a protective effect on specific disease models and a devastating impact on different ones.
“These findings highlight the fact that the same bacterial metabolite could have a protective effect on specific disease models and a devastating impact on different ones.”
Quote in the paperSubstantial claim - Premisecitation
In the rotenone-induced PD mouse model, significant changes in the composition of caecum mucosal-associated and luminal microbiota, with a decrease in abundance of Bifidobacterium genus, were associated with alterations in metabolic pathways expressed by commensal bacteria.
“In a different PD animal model, the pesticide rotenone-induced mouse model, researchers reported significant changes in the composition of caecum mucosal-associated and luminal microbiota, with a decrease in abundance of Bifidobacterium genus. These differences were associated with alterations in the metabolic pathways expressed by the commensal bacteria (184).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [184] Perez-Pardo, 2018, Gut bacterial composition in a mouse model of Parkinson’s disease, Benef Microbes source
Not checked in the free run.
- Interpretationreasoning
In the ASO model, only live bacteria producing active metabolites such as SCFAs could promote inflammation and development of the disease.
“Altogether, this work suggests that only live bacteria, producing active metabolites, such as SCFAs, could promote inflammation and development of the disease in the ASO model.”
Quote in the paperSubstantial claim - Premisecitation
Administration of probiotics (Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium bifidum) to MDD patients significantly reduced depressive symptoms compared to placebo.
“An additional study suggested that the administration of probiotics (Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium bifidum) to MDD patients significantly reduced depressive symptoms compared to placebo (187).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [187] Akkasheh, 2016, Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial, Nutrition source
Not checked in the free run.
- Premisecitation
Bacterial capacity to synthesize 3,4-dihydroxyphenylacetic acid, a dopamine metabolite, correlates positively with mental quality of life.
“From fecal metagenomic data, the bacterial capacity to synthesize 3,4-dihydroxyphenylacetic acid, a dopamine metabolite, correlates positively with mental quality of life and suggests a potential role of microbes to produce different neuroactive molecules during depression than during healthy conditions (22).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol source
Not checked in the free run.
- Premisecitation
There is a negative correlation between Faecalibacterium and the severity of depressive symptoms.
“The authors, therefore, reported a negative correlation between Faecalibacterium and the severity of depressive symptoms (186).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [186] Jiang, 2015, Altered fecal microbiota composition in patients with major depressive disorder, Brain Behav Immun source
Not checked in the free run.
- Premisecitation
Schizophrenia patients have an altered and less rich gut microbiota composition with 77 differently expressed operational taxonomy units compared to healthy individuals.
“Patients affected by schizophrenia have also an altered and less rich gut microbiota composition with 77 differently expressed operational taxonomy units (OTUs) compared to healthy individuals (23).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- Premisecitation
Fecal samples from schizophrenia patients transplanted into GF rodents could transfer schizophrenic-associated behaviors, such as locomotor hyperactivity and decreased anxiety- and depressive-like behaviors, in the recipients.
“The fecal samples derived from these patients were transplanted into GF rodents and could transfer schizophrenic-associated behaviors, such as locomotor hyperactivity and decreased anxiety- and depressive-like behaviors, in the recipients (23).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- Interpretationcitation
Microbes may produce different neuroactive molecules during depression than during healthy conditions.
“From fecal metagenomic data, the bacterial capacity to synthesize 3,4-dihydroxyphenylacetic acid, a dopamine metabolite, correlates positively with mental quality of life and suggests a potential role of microbes to produce different neuroactive molecules during depression than during healthy conditions (22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol source
Not checked in the free run.
- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Premisecitation
Mice that received fecal samples from schizophrenic patients showed several differentially regulated metabolic pathways in the feces, serum, and hippocampus.
“The mice that received fecal samples from schizophrenic patients showed several differentially regulated metabolic pathways in the feces, serum, and hippocampus (23).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- Premisecitation
Glutamine and GABA were elevated in the hippocampus of mice receiving schizophrenia patient feces.
“In particular, glutamine and GABA were elevated in the hippocampus (23).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- Premisecitation
Glutamate was decreased in the stool and hippocampus of mice receiving schizophrenia patient feces compared to mice transplanted with healthy patient feces.
“Glutamate was decreased in the stool and hippocampus of these mice, compared to mice transplanted with healthy patient’s feces (23).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Zheng, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice, Sci Adv source
Not checked in the free run.
- Premisecitation
ASD-like behaviors in GF mice colonized with ASD microbiota seemed due to a deficit in production of two bacterial metabolites, 5-aminovaleric acid and taurine, both weak GABAA agonists, in ASD individuals compared to controls.
“This approach seemed to be due to a deficit in the production of two bacterial metabolites, 5-aminovaleric acid (5-AV) and taurine, both being weak GABAA agonists, in ASD individuals compared to controls (113).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [113] Sharon, 2019, Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice, Cell source
Not checked in the free run.
- Interpretationreasoning
In MIA animal models, specific commensal bacteria are important in ASD protection.
“In MIA animal models, scientists highlighted the importance of specific commensal bacteria in ASD protection.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Rests on an assumption: The composition and function of the gut microbiota in mice and humans are sufficiently similar for mouse FMT or colonization results to inform human disease mechanisms.
- Premisecitation
Injection of the 4EPS metabolite alone in naive healthy animals was sufficient to induce anxiety-like behaviors similar to those shown by MIA offspring.
“Remarkably, the injection of the only 4EPS metabolite in the naïve healthy animals was sufficient to induce anxiety-like behaviors similar to the ones showed by the MIA offspring (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell source
Not checked in the free run.
- Premisecitation
Colonizing GF mice with fecal microbiota from patients affected by ASD was sufficient to promote ASD-like behaviors in the animals.
“Colonizing GF mice with fecal microbiota from patients affected by ASD was sufficient to promote ASD-like behaviors in the animals (113).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [113] Sharon, 2019, Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice, Cell source
Not checked in the free run.
- Premisecitation
Inflammasome activation has an essential role in the progression of several neurological disorders like MS, AD, PPD, and NPS.
“In the CNS, inflammasome activation has been mainly linked to neuroinflammatory conditions. As example, it has an essential role in the progression of several neurological disorders like MS, AD, PPD, and NPS (132, 193–197).”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- cites [193] Macia, 2015, Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome, Nat Commun source
Not checked in the free run.
- cites [194] Elinav, 2011, NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis, Cell source
Not checked in the free run.
- cites [195] Gris, 2010, NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses, J Immunol source
Not checked in the free run.
- cites [196] Kajitani, 2020, Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression, Neuropsychopharmacol Rep source
Not checked in the free run.
- cites [197] Ising, 2019, NLRP3 inflammasome activation drives tau pathology, Nature source
Not checked in the free run.
- Premisecitation
The differences in microbiota composition after minocycline or chronic restraint stress resemble those reported in caspase-1-deficient mice, such as an increase in the relative abundance of Lachnospiraceae.
“The differences in microbiota composition resemble the ones reported in caspase-1–deficient mice, such as an increase in the relative abundance of Lachnospiraceae (198).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [198] Brinkman, 2011, Caspase deficiency alters the murine gut microbiome, Cell Death Dis source
Not checked in the free run.
- Premisecitation
Expression of IL-1β increases during long-term potentiation in neurons.
“In 1998, Schneider H. et al. could show that expression of IL-1β increases during long-term potentiation in neurons, which consists in a synaptic strengthening process implicated in learning and memory (203).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] Schneider, 1998, A neuromodulatory role of interleukin-1beta in the hippocampus, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
AIM2 inflammasome has a role in normal brain development.
“Recently, AIM2 inflammasome has been shown to have a role in the normal brain development.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [205] Lammert, 2020, AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment, Nature source
Not checked in the free run.
- Premisecitation
IL-1β and IL-18 have essential roles for physiological functions in the CNS, as they participate in processes of cognition, learning, and memory.
“Moreover, IL-1β and IL-18 also have essential roles for physiological functions in the CNS, as they participate in processes of cognition, learning, and memory (201).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [201] Tsai, 2017, Effects of interleukin-1beta polymorphisms on brain function and behavior in healthy and psychiatric disease conditions, Cytokine Growth Factor Rev source
Not checked in the free run.
- Premisecitation
In different facilities, mice lacking ASC, NLRP6, or NLRP3 fail to show any detectable differences in the composition of their fecal flora compared to wild-type controlled littermates, either co-housed or individually housed, contrary to what has been described in other facilities.
“In fact, in different facilities, mice lacking ASC, NLRP6 (199), or NLRP3 (200) fail to show any detectable differences in the composition of their fecal flora compared to wild-type controlled littermates (199), either co-housed or individually housed, contrary to what has been described in other facilities (194).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [199] Mamantopoulos, 2017, Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition, Immunity source
Not checked in the free run.
- cites [200] Lemire, 2017, The NLR Protein NLRP6 Does Not Impact Gut Microbiota Composition, Cell Rep source
Not checked in the free run.
- cites [194] Elinav, 2011, NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis, Cell source
Not checked in the free run.
- Premisecitation
Maternal-microbiota inheritance or the cage effect had a much more substantial impact on intestinal bacteria composition than host inflammasome expression in our conditions.
“Instead, the maternal-microbiota inheritance or the cage effect had a much more substantial impact on the intestinal bacteria composition than the host inflammasome expression in our conditions (58).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Hansen, 2018, The microbiotic highway to health—New perspective on food structure, gut microbiota, and host inflammation, Nutrients source
Not checked in the free run.
- Premisecitation
High abundance of IL-1β has been described in steady-state in the hippocampus and hypothalamus of rats.
“Especially in the hippocampus and hypothalamus, high abundance of IL-1β has been described in steady-state in rats already in 1990, in regions of the brain conducting essential and conserved brain functions as memory and learning processes (202).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202] Lechan, 1990, Immunoreactive interleukin-1β localization in the rat forebrain, Brain Res source
Not checked in the free run.
- Premisecitation
IL-1β administration into the hippocampus induced memory impairments in a conditioning learning task in rats.
“However, in a study from 2004, IL-1β administration into the hippocampus induced memory impairments in a conditioning learning task in rats (204).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [204] Barrientos, 2004, BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1β administration, J Neuroimmunol source
Not checked in the free run.
- Interpretationreasoning
Inflammasomes and IL-1β have a complex role in the CNS.
“This discrepancy underlies the complex role of inflammasomes and IL-1β in the CNS.”
Quote in the paperSubstantial claim - Premisecitation
AIM2 inflammasome is activated in the presence of DNA damage that occurs at high levels during infections, trauma, and neurodevelopment upon massive cell death.
“It gets activated in presence of DNA damage that occurs at high levels during infections, trauma, but also neurodevelopment upon massive cell death (205).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [205] Lammert, 2020, AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment, Nature source
Not checked in the free run.
- Premisecitation
Released IL-18 importantly contributes to maintaining homeostasis in the gut.
“It has been shown that released IL-18 importantly contributes to maintaining homeostasis in the gut (193).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [193] Macia, 2015, Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome, Nat Commun source
Not checked in the free run.
- Premisecitation
BAA485, a microbiota-derived bile acid metabolite, can induce the production of IL-18 in a pyrin-inflammasome-dependent manner.
“Researchers have identified that an analogue of oxo-12S-hydroxylithocholic acid methyl ester (BAA473), a microbiota-derived bile acid metabolite, the 11-12-oxo-lithocholic acid (BAA485) can induce the production of IL-18, in a pyrin-inflammasome-dependent manner (214).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [214] Alimov, 2019, Bile acid analogues are activators of pyrin inflammasome, J Biol Chem source
Not checked in the free run.
- Interpretationcitation
Intestinal inflammasome activation by the microbiota might lead to the production of effector molecules which have an effect in the CNS via the vagus nerve.
“These data show that intestinal inflammasome activation by the microbiota might lead to the production of effector molecules which have an effect in the CNS via the vagus nerve (212).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [212] Rao, 2017, Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmission, Cell source
Not checked in the free run.
- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Premisecitation
Inflammasome signaling in the CNS has been reported in microglia, astrocytes, perivascular brain-resident macrophages, oligodendrocytes, endothelial cells, and neurons.
“Inflammasome signaling in the CNS has also been reported in the microglia, the brain’s critical innate immune cells (206), in astrocytes (207), perivascular brain-resident macrophages (208), oligodendrocytes (209), endothelial cells (210), as well as in neurons (211).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [206] Gustin, 2015, NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes, PloS One source
Not checked in the free run.
- cites [207] Freeman, 2017, NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes, J Exp Med source
Not checked in the free run.
- cites [208] Kawana, 2013, Reactive astrocytes and perivascular macrophages express NLRP3 inflammasome in active demyelinating lesions of multiple sclerosis and necrotic lesions of neuromyelitis optica and cerebral infarction, Clin Exp Neuroimmunol source
Not checked in the free run.
- Premisecitation
PTX induced recruitment of inflammatory monocytes and neutrophils in the draining lymph nodes, which were responsible for IL-1β production in the tissue.
“The toxin induced the recruitment of inflammatory monocytes and neutrophils in the draining lymph-nodes which were responsible of the production of IL-1β in the tissue (132).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- Premisecitation
IL-1β-producing lymphoid myeloid cells were needed for priming of multifunctional encephalitogenic T cells producing IL-17A, IFN-γ, GM-CSF, and IL-22.
“IL-1β–producing lymphoid myeloid cells were needed for the priming of multifunctional encephalitogenic T cells, characterized by the production of IL-17A, IFN-γ, GM-CSF, and IL-22 (132).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- Interpretationreasoning
Infectious agent products could be crucial in activation of the inflammasome pathway in MS pathogenesis.
“In summary, the infectious agent products could be crucial in the activation of the inflammasome pathway in MS pathogenesis.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
- Premisecitation
IL-1β expression and production (but not IL-18, IL-1α, IL-6, or IL-23) was transiently and shortly increased post-PTX (and not PBS) injections in the draining lymph nodes during the priming phases of the EAE disease model.
“In addition, we showed that expression and production of IL-1β (and not IL-18, IL-1α, IL-6, or IL-23) was transiently and shortly increased post-PTX (and not PBS) injections, in the draining lymph-nodes, during the priming phases of the disease model (132).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- Interpretationreasoning
Intestinal inflammasome activation could be one of the innate immune pathways activated by intestinal microbes with important distal effects also on the CNS, potentially during both healthy and inflammatory conditions.
“This could be one of the innate immune pathway activated by the intestinal microbes with important distal effects also on the CNS, potentially during both healthy and inflammatory conditions.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
- Premisecitation
Higher expression of IL-1β and IL-18 has been reported in microglia, astrocytes, and neurons surrounding Aβ plaques or in plasma of AD patients.
“Inflammasome and its products have been implicated in AD pathogenesis since a higher expression of IL-1β and IL-18 has been reported in the microglia, astrocytes, and neurons that surround Aβ plaques or in the plasma of AD patients (221–225).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [221] Griffin, 1989, Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease, Proc Natl Acad Sci USA source
Not checked in the free run.
- cites [222] Simard, 2006, Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease, Neuron source
Not checked in the free run.
- cites [223] Ojala, 2009, Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients, Neurobiol Aging source
Not checked in the free run.
- cites [224] Malaguarnera, 2006, Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer’s disease and vascular dementia, Neuropathology source
Not checked in the free run.
- cites [225] Öztürk, 2007, The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: Correlation with cognitive and functional decline, Behav Neurol source
Not checked in the free run.
- Premisecitation
IL-1β signaling at both T and non-T cells was necessary to generate the immune reactions involved in EAE disease development.
“Interestingly we have also shown that the signaling of IL-1β both at the level of T and non-T cells was necessary to generate the immune reactions involved in the disease development (132).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- Premisecitation
The increase in IL-1β occurred earlier than the appearance of any clinical symptom in the EAE model.
“This happened earlier than the appearance of any clinical symptom (132).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- Premisecitation
ASC particles physically bind to Aβ, seed, and spread Aβ pathology in a prion-like manner by promoting misfolded proteins to aggregate and form plaques.
“They were shown to physically bind to Aβ, seed, and then spread Aβ pathology in a prion-like manner by promoting misfolded proteins to aggregate and form plaques (229).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [229] Venegas, 2017, Microglia-derived ASC specks crossseed amyloid-β in Alzheimer’s disease, Nature source
Not checked in the free run.
- Interpretationreasoning
NLRP3 inflammasome-mediated neuroinflammation is importantly implicated in pathogenesis and progression of AD.
“NLRP3 inflammasome-mediated neuroinflammation has been importantly implicated in pathogenesis and progression of AD.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
- Premisecitation
Fibrillar Aβ amyloids can induce secretion of IL-1β from microglia via the NLRP3 inflammasome.
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Patients affected by tauopathies showed elevated levels of cleaved caspase-1 and ASC and mature IL-1β in the cortex.
“In general, patients affected by tauopathies showed elevated levels of cleaved caspase-1 and ASC and mature IL-1β in the cortex (197).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [197] Ising, 2019, NLRP3 inflammasome activation drives tau pathology, Nature source
Not checked in the free run.
- Premisecitation
NLRP3 inflammasome activity leads to extracellular release of ASC particles that may function as danger signals.
“In turn, NLRP3 inflammasome activity leads to the extracellular release of ASC particles that may function as danger signals (246).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [246] Baroja-Mazo, 2014, The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response, Nat Immunol source
Not checked in the free run.
- Premisecitation
Tau22 mice had increased levels of cleaved caspase-1 and ASC in their brain at 11 months compared to 3-month-old counterparts.
“Also, Tau22 mice, another model of AD and other tauopathies, had increased levels of cleaved caspase-1 and ASC in their brain at the age of 11 months compared to their 3-month-old counterparts.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197] Ising, 2019, NLRP3 inflammasome activation drives tau pathology, Nature source
Not checked in the free run.
- Premisecitation
Higher expression of NLRP3, ASC, caspase-1, caspase-5, IL-1β, and IL-18 was found in PBMCs of AD patients.
“The higher expression of NLRP3, ASC, caspase-1, caspase-5, IL-1β, and IL-18 was additionally found in the PBMCs of AD patients (224, 226, 227).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [224] Malaguarnera, 2006, Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer’s disease and vascular dementia, Neuropathology source
Not checked in the free run.
- cites [226] Saresella, 2016, The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease, Mol Neurodegener source
Not checked in the free run.
- cites [227] Bossù, 2008, Interleukin-18 produced by peripheral blood cells is increased in Alzheimer’s disease and correlates with cognitive impairment, Brain Behav Immun source
Not checked in the free run.
- Premisecitation
ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain compared to wild type after injection of Aβ into the striatum.
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [228] Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-β, Nat Immunol source
Not checked in the free run.
- Interpretationcitation
NLRP3 activation is upstream of the Aβ-tau cascade and tau pathology.
“suggesting that NLRP3 activation is upstream the Aβ-tau cascade and tau pathology (197).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197] Ising, 2019, NLRP3 inflammasome activation drives tau pathology, Nature source
Not checked in the free run.
- Premisecitation
Injection of brain homogenates from APP/PS1 or wild-type mice into the hippocampus of Tau22 mice induced tau hyperphosphorylation in Tau22 wild-type but not Tau22/Pycard−/− or Tau22/Nlrp3−/− deficient mice.
“Injecting brain homogenates from APP/PS1 or wild-type mice into the hippocampus of Tau22 mice, induced tau hyperphosphorylation in the hippocampus of Tau22 wild-type but not Tau22/Pycard−/− or Tau22/Nlrp3−/− deficient mice”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197] Ising, 2019, NLRP3 inflammasome activation drives tau pathology, Nature source
Not checked in the free run.
- Premisecitation
Pharmacological inhibition of NLRP3 inflammasome reduced Aβ deposition, neuroinflammation, and cognitive impairment in the APP/PS1 AD mouse model.
“In addition, the pharmacological inhibition of the NLRP3 inflammasome reduced Aβ deposition, neuroinflammation, and cognitive impairment in the APP/PS1 AD mouse model (231).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [231] Dempsey, 2017, Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice, Brain Behav Immun source
Not checked in the free run.
- Premisereasoning
NLRP3 activation induces tau hyperphosphorylation and aggregation in an IL-1β-dependent manner.
“Moreover, NLRP3 activation induces tau hyperphosphorylation and aggregation in an IL-1β–dependent manner.”
Quote in the paperSubstantial claim - Premisecitation
Low-grade HSV-1 infection induced an AD-like phenotype in brain organoids derived from hiNSCs.
“This work, furthermore, showed that low-grade HSV-1 infection induced an AD-like phenotype in brain organoids derived from hiNSCs (236).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [236] Cairns, 2020, A 3D human brain–like tissue model of herpes-induced Alzheimer’s disease, Sci Adv source
Not checked in the free run.
- Premisecitation
HSV-1 infection of human-induced neural stem cell lines in vitro induced gliosis and inflammation, including production of IL-1β, IL-6, and IFN-γ.
“The authors showed that infecting human-induced neural stem cell (hiNSC) lines with HSV-1 in vitro induced gliosis and inflammation, including the production of pro-inflammatory cytokines such as IL-1β, IL-6, and IFN-γ.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [236] Cairns, 2020, A 3D human brain–like tissue model of herpes-induced Alzheimer’s disease, Sci Adv source
Not checked in the free run.
- Premisecitation
IL-1β injection into the cerebral hemisphere increases Aβ-APP proteins in wild-type rats.
“IL-1β injection into the cerebral hemisphere increases Aβ-APP proteins in wild-type rats (234).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [234] Sheng, 1996, In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis, Neurobiol Aging source
Not checked in the free run.
- Premisecitation
Sustained overexpression of IL-1β in the hippocampus in APP/PS1 mice reduced plaque pathology.
“However, IL-1β seems to have an intricate role, since a sustained overexpression in the hippocampus in APP/PS1 mice was shown to reduce plaque pathology (235).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [235] Shaftel, 2007, Sustained hippocampal IL-1 b overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology Find the latest version : Sustained hippocampal IL-1 β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer pl, J Clin Invest source
Not checked in the free run.
- Premisecitation
Active caspase-1 directly cleaves α-synuclein, promoting aggregation and neuronal toxicity of the newly aggregated α-synuclein.
“In animal models, active caspase-1 was shown to directly cleave α-synuclein, which further promoted the aggregation and neuronal toxicity for neurons of this newly-aggregated α-synuclein (240).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [240] Wang, 2016, Gut microbiota-brain axis, Chin Med J (Engl) source
Not checked in the free run.
- Premisecitation
Increased IL-1β and caspase-1 have been measured in serum and striatum of PD patients.
“Increased IL-1β and caspase-1 have been measured in the serum and the striatum of PD patients (237).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [237] Mogi, 1994, Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients, Neurosci Lett source
Not checked in the free run.
- Premisecitation
Early-onset PD patients with mutations in PARK2 and PARK2, or mice lacking PINK1, showed exacerbated NLRP3 inflammasome response in microglia and macrophages.
“Additionally, early-onset PD patients with mutations in two genes encoding for parkins (PARK2 and PARK2), or mice lacking a mitochondrial serine/threonine protein kinase (PINK1) showed an exacerbated NLRP3 inflammasome response in their microglia and macrophages (239).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [239] Mouton-Liger, 2018, Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop, Glia source
Not checked in the free run.
- Premisecitation
Increased expression and activity of NLRP3 inflammasome machinery in circulating immune cells have been reported in patients with depression, bipolar disorder, and ASD.
“Increased expression and activity of the NLRP3 inflammasome machinery in circulating immune cells of patients affected by depression (245), bipolar disorder (246), and ASD (226), have been reported.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [245] Alcocer-Gómez, 2016, Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome, Mol Neurobiol source
Not checked in the free run.
- cites [246] Baroja-Mazo, 2014, The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response, Nat Immunol source
Not checked in the free run.
- cites [226] Saresella, 2016, The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease, Mol Neurodegener source
Not checked in the free run.
- Premisecitation
Plasma levels of IL-1β, IL-18, IL-1Ra, TNF-α, and IL-6 were more elevated in psychiatric patients compared to healthy controls.
“Also, at the protein level, the amount of plasma IL-1β, IL-18, IL-1Ra, TNF-α, and IL-6 were more elevated in the psychiatric patients compared to the healthy controls (248).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [248] Hylén, 2020, Increased inflammasome activity in markedly ill psychiatric patients: An explorative study, J Neuroimmunol source
Not checked in the free run.
- Premisecitation
In 40 psychiatric patients with SSD, ASD, OCD, or NSSID, expression of genes encoding NLRP3, caspase-1, ASC, IL-1β, IL-1RN, and TNF is significantly increased in peripheral whole blood compared to matched healthy controls.
“In a recent work, involving 40 psychiatric patients affected by schizophrenia spectrum disorders (SSD) (including psychotic disorder, schizophrenia, and schizoaffective disorder), ASD, obsessive-compulsive disorder (OCD), or non-suicidal self-injury disorder (NSSID), expression of genes encoding for NLRP3, caspase-1, ASC, IL-1β, IL-1RN, and TNF are significantly increased in peripheral whole blood”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [248] Hylén, 2020, Increased inflammasome activity in markedly ill psychiatric patients: An explorative study, J Neuroimmunol source
Not checked in the free run.
- Premisecitation
Release of IL-1β and TNF-α caused by stress is tightly regulated by NLRP3 inflammasome.
“The release of IL-1β and TNF-α caused by stress is tightly regulated by NLRP3 inflammasome (254).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [254] Iwata, 2016, Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor, Biol Psychiatry source
Not checked in the free run.
- Premisecitation
β-hydroxybutyrate (BHB) has an inhibitory effect on NLRP3 inflammasome.
“Specifically, the β-hydroxybutyrate (BHB), a physiological ketone body produced by the liver in condition of fasting, low blood sugar, or carbohydrate-free (like ketogenic) diet consumption had an inhibitory effect on NLRP3-inflammasome (253).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [253] Youm, 2015, The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease, Nat Med source
Not checked in the free run.
- Premisecitation
In rats, repeated subcutaneous injections of BHB attenuated stress-induced IL-1β and TNF-α expression in the hippocampus.
“In rats, repeated subcutaneous injections of BHB attenuated stress-induced IL-1β and TNF-α expression in the hippocampus.”
Quote in the paperSubstantial claim - Premisecitation
Antidepressant drugs can inhibit inflammasome activation, especially NLRP3, reducing serum IL-1β and IL-18 and protein levels of NLRP3 and IL-1β.
“Antidepressant drugs can have an inhibitory effect on inflammasome activation, especially on NLRP3 inflammasome, as they reduce serum levels of IL-1β and IL-18 and protein levels of NLRP3 and IL-1β (247).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [247] Alcocer-Gómez, 2017, Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder, Pharmacol Res source
Not checked in the free run.
- Interpretationnone given
The inflammasome is involved in several neurological and intestinal homeostatic and inflammatory conditions.
“As shown, it is involved in several neurological and intestinal homeostatic and inflammatory conditions.”
Quote in the paperSubstantial claim - Premisecitation
In some cases, the inflammasome is involved in the pathogenesis of neurodegenerative diseases, such as EAE, upon bacterial exposure.
“In some cases, it is involved in the pathogenesis of neurodegenerative diseases, such as EAE, upon bacterial exposure (132).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
- Premisecitation
Inflammasome products are targets of several therapies used to treat some of the disorders presented in the review.
“Inflammasome products are targets of several therapies used to treat some of the disorders that we have presented here (256).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [256] Song, 2017, NLRP3 inflammasome in neurological diseases, from functions to therapies, Front Cell Neurosci source
Not checked in the free run.
- Interpretationreasoning
Bacteria, both pathogens and commensals, have the capacity to stimulate the host intestinal tissue and signal to the brain to promote several aspects of host behaviors and neurological disease pathogenesis.
“Overall, we think that the exciting and important discoveries here summarized suggest that bacteria, both pathogens and commensals, have the capacity to stimulate the host intestinal tissue and signal to the brain to promote several aspects of the behaviors of the host and the neurological disease pathogenesis.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
- May combine two claims. 84
- Classified as probably not a substantial claim. 4
- The quote only partly states this claim. 2
May combine two claims.
Premisenone givenDuring dysbiosis, gut-brain axis pathways are dysregulated and associated with altered blood-brain barrier permeability and neuroinflammation.
“During dysbiosis, these pathways are dysregulated and associated with altered permeability of the blood-brain barrier (BBB) and neuroinflammation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenThe inflammasome pathway has been linked to neuroinflammatory conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, and anxiety and depressive-like disorders.
“Among those, the inflammasome pathway has been linked to neuroinflammatory conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, but also anxiety and depressive-like disorders.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenThe inflammasome complex assembles upon cell activation due to exposure to microbes, danger signals, or stress and leads to production of pro-inflammatory cytokines interleukin-1β and interleukin-18 and to pyroptosis.
“The inflammasome complex assembles upon cell activation due to exposure to microbes, danger signals, or stress and lead to the production of pro-inflammatory cytokines (interleukin-1β and interleukin-18) and to pyroptosis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFunctional immune cells can enter the CNS through the blood-brain barrier, choroid plexus, and lymphatic vessels and have been described beyond neuropathological conditions.
“However, the idea that the CNS is an immune privileged organ has been reconsidered, as the functional immune cells can enter the CNS through the BBB, the choroid plexus, and the lymphatic vessels and have been described beyond neuropathological conditions (26, 35–47).”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [26] Inserra, 2018, The Microbiota-Inflammasome Hypothesis of Major Depression, BioEssays source
Not checked in the free run.
- cites [35] Suter, 2003, The brain as an immune privileged site: Dendritic cells of the central nervous system inhibit T cell activation, Eur J Immunol source
Not checked in the free run.
- cites [36] Aspelund, 2015, A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules, J Exp Med source
Not checked in the free run.
- cites [37] Biragyn, 2017, Potential importance of B cells in aging and aging-associated neurodegenerative diseases, Semin Immunopathol source
Not checked in the free run.
- cites [38] Ankeny, 2010, B cells and autoantibodies: Complex roles in CNS injury, Trends Immunol source
Not checked in the free run.
- cites [39] Alter, 2003, Determinants of Human B Cell Migration Across Brain Endothelial Cells, J Immunol source
Not checked in the free run.
- cites [40] Negi, 2018, CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ, Int Rev Immunol source
Not checked in the free run.
- cites [41] Ribeiro, 2019, Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory, Sci Immunol source
Not checked in the free run.
- cites [42] Kipnis, 2012, Pro-cognitive properties of T cells, Nat Rev Immunol source
Not checked in the free run.
- cites [43] Ellwardt, 2016, Understanding the Role of T Cells in CNS Homeostasis, Trends Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationBacterial products and metabolites can pass the blood-brain barrier and shape CNS development and functions and the genesis of certain diseases.
“Among the molecules that can pass the BBB are also bacterial products and metabolites shaping not only the CNS development and functions (6, 15) but also the genesis of certain diseases (33–42).”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [6] Uchimura, 2018, Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response, Immunity source
Not checked in the free run.
- cites [15] Buffington, 2016, Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring, Cell source
Not checked in the free run.
- cites [33] Engelhardt, 2014, Novel insights into the development and maintenance of the blood-brain barrier, Cell Tissue Res source
Not checked in the free run.
- cites [34] Daneman, 2015, The blood-brain barrier, Cold Spring Harb Perspect Biol source
Not checked in the free run.
- cites [35] Suter, 2003, The brain as an immune privileged site: Dendritic cells of the central nervous system inhibit T cell activation, Eur J Immunol source
Not checked in the free run.
- cites [36] Aspelund, 2015, A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules, J Exp Med source
Not checked in the free run.
- cites [37] Biragyn, 2017, Potential importance of B cells in aging and aging-associated neurodegenerative diseases, Semin Immunopathol source
Not checked in the free run.
- cites [38] Ankeny, 2010, B cells and autoantibodies: Complex roles in CNS injury, Trends Immunol source
Not checked in the free run.
- cites [39] Alter, 2003, Determinants of Human B Cell Migration Across Brain Endothelial Cells, J Immunol source
Not checked in the free run.
- cites [40] Negi, 2018, CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ, Int Rev Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationThe microbiota orchestrates the local immune system in the intestine and shapes immune and non-immune cells located at distal sites and acting systemically.
“Notably, the microbiota orchestrates the local immune system in the intestine (67), and shapes immune and non-immune cells located in distal sites and acting systemically (68, 69).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [67] Grigg, 2017, Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases, J Immunol source
Not checked in the free run.
- cites [68] Kieper, 2005, Cutting Edge: Recent Immune Status Determines the Source of Antigens That Drive Homeostatic T Cell Expansion, J Immunol source
Not checked in the free run.
- cites [69] McCoy, 2017, Host-microbiota interactions and adaptive immunity, Immunol Rev source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationUnder healthy conditions, the microbiota influences numerous physiological processes within the host, including protection against pathogens, nutrient digestion and absorption, development, and education of multiple host organs and the immune system.
“Under healthy conditions, the microbiota influences numerous physiological processes within the host, such as protection against pathogens, nutrient digestion and absorption, development, and education of multiple host organs and the immune system (3–6).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [3] Lloyd-Price, 2016, The healthy human microbiome, Genome Med source
Not checked in the free run.
- cites [4] Bäckhed, 2005, Host-bacterial mutualism in the human intestine, Science (80-) source
Not checked in the free run.
- cites [5] Sommer, 2013, The gut microbiota-masters of host development and physiology, Nat Rev Microbiol source
Not checked in the free run.
- cites [6] Uchimura, 2018, Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationThe inflammasome plays a role in depressive- and anxiety-like behaviors and locomotor activity.
“Among those pathways, researchers showed that the inflammasome plays a role in depressive- and anxiety-like behaviors, and locomotor activity (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Singhal, 2014, Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment, Front Cell Neurosci source
Not checked in the free run.
May combine two claims.
PremisecitationCompared to colonized mice, germ-free mice show exaggerated hypothalamic-pituitary-adrenal stress reaction, impaired social behaviors, reduced anxiety-like behavior, and increased motor and rearing activity.
“In details, compared to colonized mice, GF mice showed exaggerated hypothalamic–pituitary–adrenal (HPA) restrain stress reaction (10), impared social behaviors (12, 15, 82), reduced anxiety-like behavior (7, 81–83) and increased motor and rearing activity (80, 84).”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [10] Sudo, 2004, Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice, J Physiol source
Not checked in the free run.
- cites [12] Desbonnet, 2014, Microbiota is essential for social development in the mouse, Mol Psychiatry source
Not checked in the free run.
- cites [15] Buffington, 2016, Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring, Cell source
Not checked in the free run.
- cites [82] Cryan, 2012, Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour, Nat Rev Neurosci source
Not checked in the free run.
- cites [7] Clarke, 2013, The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Mol Psychiatry source
Not checked in the free run.
- cites [81] Neufeld, 2011, Reduced anxiety-like behavior and central neurochemical change in germ-free mice, Neurogastroenterol Motil source
Not checked in the free run.
- cites [83] Cryan, 2019, The microbiota-gut-brain axis, Physiol Rev source
Not checked in the free run.
May combine two claims.
PremisecitationAntibiotic treatment results in reduced expression of the tight-junction forming proteins occludin and claudin-5 in the brain, increased blood-brain barrier permeability, reduced anxiety-like behaviors, and elevated exploratory behavior and home-cage activity.
“Antibiotic treatment results in reduced expression of the tight-junction forming proteins, occludin, and claudin-5, in the brain, increased BBB permeability, reduced anxiety-like behaviors, and elevated exploratory behavior and home-cage activity (35).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Suter, 2003, The brain as an immune privileged site: Dendritic cells of the central nervous system inhibit T cell activation, Eur J Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationMetabolism of tryptophan by activated microglia produces the neurotoxin quinolinic acid, an N-methyl-d-aspartate agonist, implicated in several neurological conditions, including Huntington's disease and depression.
“More recently, it has also been reported that metabolism of tryptophan by activated microglia produces the neurotoxin quinolinic acid, an N-methyl-d-aspartate agonist, implicated in several neurological conditions, including Huntington’s disease and depression (90).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [90] Feng, 2017, Microglia activation contributes to quinolinic acid-induced neuronal excitotoxicity through TNF-α, Apoptosis source
Not checked in the free run.
May combine two claims.
PremisecitationColonizing germ-free animals post-weaning was sufficient to restore tryptophan levels in the periphery and reduce anxiety in germ-free animals, but insufficient to reverse CNS neurochemical consequences present in adult germ-free animals.
“Interestingly, colonizing GF animals post-weaning was sufficient to restore the levels of tryptophan in the periphery and to reduce anxiety in GF animals, but was insufficient to reverse the CNS neurochemical consequences present in adult GF animals (7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Clarke, 2013, The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Mol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment with L. johnsonii restored a healthy gut microbiota composition and attenuated both colitis and E. coli-induced memory impairment.
“In contrast, the treatment with L. johnsonii restored a healthy gut microbiota composition and attenuated both colitis and E. coli-induced memory impairment (95, 96).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [95] Jang, 2018, Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice, Mucosal Immunol source
Not checked in the free run.
- cites [96] Lee, 2018, Lactobacillus johnsonii CJLJ103 Attenuates Scopolamine-Induced Memory Impairment in Mice by Increasing BDNF Expression and Inhibiting NF-κB Activation, J Microbiol Biotechnol source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment of mice with E. coli isolated from colitic mice caused colitis and brain memory impairment.
“Moreover, the treatment of mice with E. coli, isolated from colitic mice, caused colitis and brain memory impairment (95, 96).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [95] Jang, 2018, Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice, Mucosal Immunol source
Not checked in the free run.
- cites [96] Lee, 2018, Lactobacillus johnsonii CJLJ103 Attenuates Scopolamine-Induced Memory Impairment in Mice by Increasing BDNF Expression and Inhibiting NF-κB Activation, J Microbiol Biotechnol source
Not checked in the free run.
May combine two claims.
PremisecitationA small fraction of short-chain fatty acids reaches the systemic circulation and can cross the blood-brain barrier using their own transporters located on brain vascular epithelial cells.
“A small fraction reaches the systemic circulation and can cross the tightly regulated BBB using their own transporters located on brain vascular epithelial cells (100, 101).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [100] Oldendorf, 1973, Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids, Am J Physiol source
Not checked in the free run.
- cites [101] Silva, 2020, The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication, Front Endocrinol (Lausanne) source
Not checked in the free run.
May combine two claims.
PremisecitationShort-chain fatty acids maintain gut health by promoting intestinal barrier integrity, mucus production, and supporting a tolerogenic response over inflammation.
“SCFAs maintain gut health by promoting intestinal barrier integrity, mucus production, and supporting a tolerogenic response over inflammation (49, 50, 98, 99).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [49] O’Keefe, 2016, Diet, microorganisms and their metabolites, and colon cancer, Nat Rev Gastroenterol Hepatol source
Not checked in the free run.
- cites [50] Peng, 2009, Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, J Nutr source
Not checked in the free run.
- cites [98] Gaudier, 2009, Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon, Physiol Res
Not checked in the free run.
- cites [99] Smith, 2013, The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis, Bone source
Not checked in the free run.
May combine two claims.
PremisecitationPropionate and butyrate can influence cell signaling via modification of intracellular potassium levels and regulate expression of tryptophan 5-hydroxylase 1 and tyrosine hydroxylase.
“Propionate and butyrate can influence the cell signaling system via modification of the intracellular potassium levels (104), and they regulate the expression levels of tryptophan 5-hydroxylase 1, involved in the synthesis of serotonin, and tyrosine hydroxylase, which is involved in the biosynthesis of dopamine, adrenaline, and noradrenaline (105).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [104] Oleskin, 2016, Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota, Microb Ecol Health Dis source
Not checked in the free run.
- cites [105] Nankova, 2014, Enteric Bacterial Metabolites Propionic and Butyric Acid Modulate Gene Expression, Including CREB-Dependent Catecholaminergic Neurotransmission, in PC12 Cells - Possible Relevance to Autism Spectrum Disorders, PloS One source
Not checked in the free run.
May combine two claims.
PremisecitationMultiple sclerosis patients with active disease have an altered microbiota compared to patients in the remission phase, who have a microbiota more similar to healthy controls.
“Interestingly, even MS patients with active disease have an altered microbiota compared to patients in the remission phase, which in turn have a microbiota more similar to healthy controls (25, 134–138).”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [25] Chen, 2016, Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls, Sci Rep source
Not checked in the free run.
- cites [134] Miyake, 2015, Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters, PLos One source
Not checked in the free run.
- cites [135] Cantarel, 2015, Gut microbiota in multiple sclerosis: possible influence of immunomodulators, J Investig Med source
Not checked in the free run.
- cites [136] Bhargava, 2014, Gut Microbiome and Multiple Sclerosis, Curr Neurol Neurosci Rep source
Not checked in the free run.
- cites [137] Jangi, 2016, Alterations of the human gu microbiome in multiple sclerosis, Nat Comm source
Not checked in the free run.
- cites [138] Pröbstel, 2017, The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression : Towards Characterization of the “MS Microbiome.”, Neurotherapeutics source
Not checked in the free run.
May combine two claims.
PremisecitationProbiotic supplementations have therapeutic potential to ameliorate multiple sclerosis, improving disability status, mental health, and some inflammatory and metabolic parameters compared to placebo.
“Moreover, probiotics supplementations have a therapeutic potential to ameliorate MS, improving the disability status, the mental health, and some inflammatory and metabolic parameters, compared to the placebo group (148, 149).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [148] Kouchaki, 2017, Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial, Clin Nutr source
Not checked in the free run.
- cites [149] Tankou, 2018, Investigation of probiotics in multiple sclerosis, Mult Scler source
Not checked in the free run.
May combine two claims.
PremisecitationFecal microbiota transplantation in three multiple sclerosis patients to treat severe constipation reverted the intestinal illness and improved multiple sclerosis symptoms.
“In an additional relevant study, three MS patients underwent multiple fecal microbiota transplantations (FMT) to treat severe constipation. This treatment reverted the intestinal illness and improved the MS symptoms (147), proving the existence of a gut-brain connection.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [147] Borody, 2011, Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis (MS): 942, Off J Am Coll Gastroenterol | ACG source
Not checked in the free run.
May combine two claims.
PremisecitationMultiple sclerosis patients treated with minocycline have a reduced rate of relapses and amelioration of several immunological parameters such as IL-12p40, metalloproteinase-9, and soluble vascular cell adhesion molecule-1.
“Additionally, MS patients that were treated with the antibiotic minocycline, a broad-spectrum tetracycline, have reduced rate of relapses and amelioration of several immunological parameters (such as IL-12p40, metalloproteinase-9, and soluble vascular cell adhesion molecule-1) (145, 146).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [145] Zabad, 2007, The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study, Mult Scler J source
Not checked in the free run.
- cites [146] Popovic, 2002, Inhibition of autoimmune encephalomyelitis by a tetracycline, Ann Neurol source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe intestinal microbiota was responsible for disease severity and the modulation of the adaptive immune response during experimental autoimmune encephalomyelitis development.
“This effect suggested that the intestinal microbiota was responsible for the disease severity and the modulation of the adaptive immune response during disease development (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Ochoa-Repáraz, 2009, Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis, J Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationMice treated with antibiotics alone or recolonized with the PSA-wild-type strain of B. fragilis were protected against experimental autoimmune encephalomyelitis, whereas mice recolonized with ΔPSA B. fragilis and vehicle-treated controls developed the disease.
“Mice treated with antibiotics alone or recolonized with the PSA-wild-type strain of B. fragilis were protected against disease, whereas the mice recolonized with ΔPSA B. fragilis and as well the vehicle-treated control group developed the disease (116).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [116] Ochoa-Repáraz, 2010, Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression, J Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationMultiple sclerosis patients during active relapse had less IgA specific for intestinal bacteria compared to patients in remission, suggesting the capacity of IgA-producing cells to migrate from the gut to the central nervous system during disease relapses.
“Remarkably, MS patients during active relapse had less IgA specific for intestinal bacteria compared to patients in remission, suggesting the capacity of IgA-producing cells to migrate from the gut to the central nervous system during disease relapses, as in the mouse system (151).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [151] Rojas, 2019, Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationGerm-free mice colonized with only SFB developed experimental autoimmune encephalomyelitis and a T helper 17 pathogenic immune response in the gut and CNS.
“Strikingly, GF mice colonized with only a single bacterium, the SFB, developed EAE, and a T helper (Th)-17 pathogenic immune response in the gut and in the CNS (117).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Kyung, 2011, Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis, PNAS source
Not checked in the free run.
May combine two claims.
PremisecitationCommensal-reactive IgA-producing cells expressed IL-10, and production of IL-10 (partially together with iNOS, but not IgA itself) was essential to ameliorate experimental autoimmune encephalomyelitis.
“Briefly, commensal-reactive IgA-producing cells expressed IL-10, and the production of IL-10 (partially together with iNOS, but not IgA itself) was essential to ameliorate EAE (151).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [151] Rojas, 2019, Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIL-10- and IgA-producing plasma cells have a role in ameliorating experimental autoimmune encephalomyelitis in mice and correlate with relapse in multiple sclerosis patients.
“In the recent milestone study from the groups of Gommerman J. and Baranzini SE., IL-10- and IgA-producing plasma cells have been suggested to have a role in ameliorating EAE in mice and to correlate with relapse in MS patients (151).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [151] Rojas, 2019, Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationBi-colonization with Allobaculum and L. reuteri together activated MOG-specific T cells toward a pathogenic Th17 phenotype and worsened experimental autoimmune encephalomyelitis, with demyelination and cell infiltration in the spinal cord.
“However, the bi-colonization with Allobaculum and L. reuteri together activated MOG-specific T cells toward a pathogenic Th17 phenotype and worsened EAE, with demyelination and cell infiltration in the spinal cord (152).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [152] Miyauchi, 2020, Gut microorganisms act together to exacerbate inflammation in spinal cords, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationAmpicillin administration alone ameliorated experimental autoimmune encephalomyelitis development with a reduction of proliferating CD4+ autoreactive T cells.
“Lately, in the classical acute EAE model, ampicillin administration alone ameliorated the EAE development (152) with a reduction of proliferating CD4+ autoreactive T cells.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [152] Miyauchi, 2020, Gut microorganisms act together to exacerbate inflammation in spinal cords, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationSupplementation of a cocktail of five probiotics (IRT5) before or after experimental autoimmune encephalomyelitis onset in rodents is associated with delay of disease onset or suppression of disease progression, respectively.
“The supplementation of a cocktail of five probiotics (IRT5) before or after the EAE onset in rodents is associated with the delay of the disease onset or suppression of the disease progression, respectively (154).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [154] Kwon, 2013, Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response, Clin Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationAmelioration of experimental autoimmune encephalomyelitis upon probiotic treatment was associated with a higher abundance of Treg cells, higher production of IL-10 by CD4+ T cells, B cells, and CD11c+ cells, together with suppression of the pro-inflammatory Th-1/Th-17 response.
“The amelioration of the disease upon probiotic treatment was associated with a higher abundance of Treg cells, higher production of IL-10 by CD4+ T cells, B cells, and CD11c+ cells, together with the suppression of the pro-inflammatory Th-1/Th-17 response (154).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [154] Kwon, 2013, Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response, Clin Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationProphylactic antibiotic treatment before clinical onset of spontaneous experimental autoimmune encephalomyelitis led to a significant reduction of susceptibility, accompanied by altered intestinal microbial composition and a decrease in Th-17 cell development.
“Prophylactic antibiotic treatment (at 1–3 weeks before the clinical onset of the disease, starting from 2–4 weeks of age) led to a significant reduction of susceptibility to spontaneous EAE, accompanied by altered intestinal microbial composition and a decrease in Th-17 cell development (153).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] Gödel, 2020, Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease, J Neuroinflammation source
Not checked in the free run.
May combine two claims.
PremisecitationShort-chain fatty acids favor enhancement of acetyl-CoA metabolism, histone acetylation, preservation of spinal cord lipid content, suppression of demyelination, and oligodendrocyte maturation and differentiation.
“Mechanistically, SCFAs favor the enhancement of acetyl-CoA metabolism, histone acetylation, preservation of spinal cord lipid content, suppression of demyelination, oligodendrocyte maturation and differentiation (157, 158).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [157] Chevalier, 2017, Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis, J Neurochemistry source
Not checked in the free run.
- cites [158] Chen, 2019, Butyrate suppresses demyelination and enhances remyelination, J Neurol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMicrobiota modulation in early life stages or prophylactic treatments in subjects genetically prone to autoimmune diseases such as multiple sclerosis could be efficient approaches to ameliorate disease susceptibility and/or delay onset.
“These results suggest that microbiota modulation in early life stages or prophylactic treatments in subjects that are genetically prone to develop certain autoimmune diseases, such as MS, could be efficient approaches to ameliorate the disease susceptibility and/or to delay the onset of the disease.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSeveral microbial factors have been linked to Alzheimer's disease pathogenesis, and a few studies suggested alteration in the commensal microbiota and pathogenic infections as potential causes of Alzheimer's disease.
“Several microbial factors have been linked to the AD pathogenesis (140, 141), and a few studies suggested alteration in the commensal microbiota and pathogenic infections as potential causes of AD (142).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [140] Geuking, 2011, Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses, Immunity source
Not checked in the free run.
- cites [141] Atarashi, 2011, Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species, Science (80-) source
Not checked in the free run.
- cites [142] Jia, 2017, Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationIn vitro stimulation with indoxyl-3-sulfate activated the AhR signaling pathway in primary human microglia, leading to suppression of pro-inflammatory pathways via TNF-α, IL-6, IL-12A, NOS2, and VEGF-β expression and promotion of anti-inflammatory responses such as IL-10 and TGF-α expression.
“Moreover, using primary human microglia, they showed that the in vitro stimulation with I3S activated the AhR signaling pathway leading to the suppression of pro-inflammatory pathways (via TNF-α, IL-6, IL-12A, NOS2, VEGF-β expression), and the promotion of anti-inflammatory responses (such as IL-10 and TGF-α expression) (89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Rothhammer, 2018, Microglial control of astrocytes in response to microbial metabolites, Nature source
Not checked in the free run.
May combine two claims.
Premisecitation5xFAD mice recapitulate significant Alzheimer's disease and fecal microbial composition features that evolve with age.
“Additionally, 5xFAD mice (over-expressing in the brain the mutant human APP carrying Swedish, Florida, and London Familial Alzheimer’s Disease (FAD) mutations along with human PS1 harboring two FAD mutations) recapitulate significant AD and fecal microbial composition features that evolve with age (162, 163).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [162] Brandscheid, 2017, Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model, J Alzheimers Dis source
Not checked in the free run.
- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
May combine two claims.
PremisecitationGerm-free APP/PS1 transgenic mice have reduced Aβ levels in the brain and blood and reduced amyloid load compared to conventionally-raised APP/PS1 mice.
“Importantly, GF-APP/PS1 transgenic mice have reduced Aβ levels in the brain and blood and reduced amyloid load compared to conventionally-raised APP/PS1 mice (161).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Harach, 2017, Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationNeuroinflammatory modifications were strikingly dependent on microbiota ones, and depletion of intestinal microbes via antibiotic treatment ameliorated the recruitment and priming of anti-inflammatory microglia and Th-1 cells.
“The neuroinflammatory modifications were, in fact, strikingly dependent on the microbiota ones, and the depletion of intestinal microbes via antibiotic treatment ameliorated the recruitment and priming of anti-inflammatory microglia and Th-1 cells (163).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
May combine two claims.
PremisecitationAt the age of seven months, when signs of synaptic degeneration appear, Firmicutes became the predominant phylum, with a marked decrease in abundance of Bacteroidetes and Verrucomicrobia.
“At the age of seven months, when the signs of synaptic degeneration appear, Firmicutes became the predominant phylum, with a marked decrease in abundance of Bacteroidetes and Verrucomicrobia.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThese variations over time were absent in wild-type mice, which had a much more stable microbiota throughout the lifespan.
“These variations over time were absent in wild-type mice, which had a much more stable microbiota throughout the lifespan (163).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
May combine two claims.
PremisecitationAt 2 to 3 months of age, both pro-inflammatory and anti-inflammatory microglia expanded, while in the following months only the first subset continued to grow, along with recruitment of Th-1 CD4+ proinflammatory cells, reaching a peak at seven-nine months.
“In fact, at 2 to 3 months of age, both pro-inflammatory and anti-inflammatory microglia expanded, while in the following months, only the first subset continued to grow, along with the recruitment of Th-1 CD4+ proinflammatory cells, reaching a peak at seven-nine months.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
PremisecitationFeces from oligomannate-treated 5xFAD mice transferred protection from neuroinflammatory events to recipient wild-type mice pre-treated with Aβ aggregate injections.
“The feces isolated from oligomannate-treated 5xFAD mice transferred protection from neuroinflammatory events in recipient animals (163).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] Wang, 2019, Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression, Cell Res source
Not checked in the free run.
May combine two claims.
PremisecitationSodium oligomannate suppressed neuroinflammation, Aβ plaque deposition, and cognition impairment.
“The usage of a sodium oligomannate, with known cognition improvement effect in humans, suppressed neuroinflammation, Aβ plaque deposition, and cognition impairment (164).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [164] Dong, 2019, Drug development for alzheimer’s disease: Microglia induced neuroinflammation as a target, Int J Mol Sci source
Not checked in the free run.
May combine two claims.
InterpretationcitationModifications of intestinal flora impact several metabolic pathways in AD mouse models, potentially leading to cognitive defects, amyloid deposition, and intestinal abnormalities.
“Therefore, modifications of the intestinal flora impact several metabolic pathways in AD mouse models, that could be leading to cognitive defects, amyloid deposition, and intestinal abnormalities (165).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [165] Zhang, 2017, Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease, J Alzheimers Dis source
Not checked in the free run.
- Rests on an assumption: In AD mice, intestinal microbiota diversity is altered and SCFA levels are reduced compared to wild-type control mice.
May combine two claims.
PremisecitationFMT from wild-type animals into ADLPAPT mice ameliorated formation of Aβ plaques, neurofibrillary tangles, glial reactivity, and cognitive impairment in recipient mice.
“Upon fecal microbial transplantations from WT animals into ADLPAPT mice, formation of amyloid β plaques and neurofibrillary tangles, glial reactivity and cognitive impairment were ameliorated in the recipients mice (166).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [166] Kim, 2020, Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationOral Bifidobacterium longum NK46 in 5xFAD mice changed intestinal microbiota composition, increasing Bacteroides and reducing Firmicutes and Proteobacteria phyla.
“The human isolate Bifidobacterium longum (NK46) was orally administered in 5xFAD mice and induced anti-inflammatory effects (decrease in lipopolysaccharide (LPS) levels, NF-κB activation, and TNF-α expression), changes in the intestinal microbiota composition of the recipients (increase in Bacteroides and reduction in Firmicutes and Proteobacteria phyla), and suppression of Aβ accumulation in the”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170] Lee, 2019, Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationMice that received gingipains-deficient P. gingivalis or synthetic gingipains inhibitors had significantly less P. gingivalis DNA detectable in the brain, less Aβ production, reduced neuroinflammation, and increased number of healthy neurons in the hippocampus.
“On the other hand, mice that received gingipains-deficient P. gingivalis or synthetic gingipains inhibitors had significantly less P. gingivalis DNA detectable in the brain, less Aβ production, reduced neuroinflammation, and increased number of healthy neurons in the hippocampus (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Dominy, 2019, Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors, Sci Adv source
Not checked in the free run.
May combine two claims.
PremisecitationButyrate-producing bacteria are associated with a decrease in the dopamine metabolite and lower quality of life and signs of depression.
“Those butyrate-producing bacteria are also associated with a decrease in the dopamine metabolite and lower quality of life and signs of depression (22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol source
Not checked in the free run.
May combine two claims.
PremisecitationThe ASO mouse model of PD develops progressive deficits in motor function as well as in gut motility.
“Importantly, ASO (overexpressing a-synuclein under Thy1 promoter) mouse model of PD develops progressive deficits in motor function as well as in gut motility (182, 183).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [182] Chesselet, 2012, A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice, Neurotherapeutics source
Not checked in the free run.
- cites [183] Rockenstein, 2002, Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters, J Neurosci Res source
Not checked in the free run.
May combine two claims.
PremisecitationASO GF mice show reduced signs of PD and diminished α-synuclein aggregates in the frontal cortex, but not in the cerebellum, compared to their SPF counterparts.
“ASO GF mice show reduced signs of PD and diminished α-synuclein aggregates in the frontal cortex, but not in the cerebellum, compared to their SPF counterparts (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationPD is characterized by a disrupted intestinal barrier, which leads to systemic dissemination of microbial products like LPS and an increase in expression of intestinal pro-inflammatory genes.
“Another important characteristic of the disease is a disrupted intestinal barrier, which leads to the systemic dissemination of microbial products like LPS and an increase in expression of intestinal pro-inflammatory genes (181).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [181] Perez-Pardo, 2018, Role of TLR4 in the gut-brain axis in Parkinson’s disease: A translational study from men to mice, Gut source
Not checked in the free run.
May combine two claims.
InterpretationreasoningA PD-typical microbiota composition could be associated with less dopamine production and PD.
“This finding suggests that a PD-typical microbiota composition could be associated with less dopamine production and PD.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
May combine two claims.
PremisecitationASO-GF mice treated with SCFA mixture showed mature microglia, formation of α-syn-aggregates, GI deficits, and significantly impaired performance in several motor tasks, as ASO-SPF mice.
“Remarkably, ASO-GF mice treated with SCFAs mixture showed again mature microglia, formation of α-syn-aggregates, GI deficits, and significantly impaired performance in several motor tasks, as ASO-SPF mice (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationMicroglia phenotype and gastrointestinal function (measured as fecal output) were significantly improved in antibiotic-treated animals but diminished in GF mice recolonized with SPF flora.
“Importantly, the microglia phenotype and also the gastrointestinal function (measured as fecal output) were significantly improved in antibiotic-treated animals but diminished in GF mice recolonized with SPF flora (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationRepeated oral administration of Proteus mirabilis or its derived LPS to MPTP-treated or young mice was sufficient to induce a PD-like phenotype with motor deficit, loss of dopaminergic neurons in the nigra, brain and gut inflammation with disruption of the intestinal epithelial barrier, and formation of α-syn inclusions in the brain and in the colon.
“In the end, in a differently induced model of PD, the repeated oral administration of Proteus mirabilis or its derived LPS to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated or young mice was sufficient to induce a PD-like phenotype with motor deficit, loss of dopaminergic neurons in the nigra, brain and gut inflammation with disruption of the intestinal epithelial barrier, and formation of α”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [185] Choi, 2018, Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment with minocycline reduced inflammation, α-syn-aggregates, and improved motor function.
“Moreover, the simple treatment with minocycline was adequate to reduce inflammation, α-syn-aggregates, and improve motor function (103).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Frost, 2014, The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationMDD patients had increased fecal α-diversity, with increased levels of Enterobacteriaceae and Alistipes but reduced levels of Faecalibacterium, compared to drug-responder MDD patients and healthy controls.
“Patients suffering from major depressive disorder (MDD) had increased fecal α-diversity (increased levels of Enterobacteriaceae and Alistipes but reduced levels of Faecalibacterium) compared to drug-responders-MDD patients and healthy controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [186] Jiang, 2015, Altered fecal microbiota composition in patients with major depressive disorder, Brain Behav Immun source
Not checked in the free run.
May combine two claims.
PremisecitationIn a Flemish population cohort, butyrate-producing Faecalibacterium and Coprococcus bacteria were associated with high quality of life, and Bacteroides enterotype 2 with low quality of life and signs of depression.
“From a large microbiome study on a Flemish population cohort, some bacteria have been associated with high quality of life, such as butyrate-producing Faecalibacterium, Coprococcus bacteria, and others with low quality of life and signs of depression, such as Bacteroides enterotype 2 (22).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Valles-Colomer, 2019, The neuroactive potential of the human gut microbiota in quality of life and depression, Nat Microbiol source
Not checked in the free run.
May combine two claims.
PremisecitationStudies showing the importance of microbiota in ASD pathogenesis are few and mostly inconsistent, with some exceptions concerning differences in bacteria such as Prevotella, Firmicutes, Clostridiales (like Clostridium perfringens), and Bifidobacterium species between ASD patients and controls.
“Regarding human autism spectrum disorder (ASD), studies showing the importance of the microbiota in the pathogenesis are few and mostly inconsistent, with some exceptions concerning the differences observed for bacteria, such as Prevotella, Firmicutes, Clostridiales, like Clostridium perfringens, and Bifidobacterium species (188), between the ASD patients and the controls.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [188] Ho, 2020, Gut microbiota changes in children with autism spectrum disorder: a systematic review, Gut Pathog source
Not checked in the free run.
May combine two claims.
PremisecitationIn mice, genetic deficiency of caspase-1 is associated with a decrease of innate and stress-induced depressive- and anxiety-like behaviors and affects chronic restraint stress response, with possible involvement of the intestinal microbiota.
“As mentioned earlier, in mice, the genetic deficiency of caspase-1, the effector molecule of the inflammasome, is associated with a decrease of innate and stress-induced depressive- and anxiety-like behaviors and affects chronic restraint stress response with a possible involvement of the intestinal microbiota (190).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] Wong, 2016, Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition, Mol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationAdministration of Bacteroides fragilis (and Bacteroides thetaiotaomicron but not Enterococcus faecalis) improved gut dysbiosis, intestinal barrier integrity, metabolic profile, and communicative, repetitive, anxiety-like, and sensorimotor behaviors in the MIA model.
“The pure administration of two bacterial strains as probiotic treatment, such as Bacteroides fragilis (and Bacteroides thetaiotaomicron but not Enterococcus faecalis), could improve the gut dysbiosis, intestinal barrier integrity, the metabolic profile of the animals, and the communicative, repetitive, anxiety-like, and sensorimotor behaviors in the MIA model (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationOffspring from MIA dams showed intestinal microbial dysbiosis with 67 different OTUs compared to the control group, dysregulation of intestinal barrier integrity with increased permeability, and alteration in their metabolomic profile.
“Interestingly, offspring coming from MIA dams showed intestinal microbial dysbiosis with 67 different OTUs compared to the control group, dysregulation of the intestinal barrier integrity with increased permeability, as reported already in children affected by ASD (189), and alteration in their metabolomic profile (20).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [189] Lefter, 2020, A descriptive review on the prevalence of gastrointestinal disturbances and their multiple associations in autism spectrum disorder, Med source
Not checked in the free run.
- cites [20] Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIn the MIA model, 4-ethylphenylsulfate, indole pyruvate, serotonin, glycolate, imidazole propionate, and N-acetylserine were enormously increased in the serum of MIA offspring and entirely restored by single B. fragilis treatment.
“Concerning the metabolites that could be induced by the intestinal bacteria under certain pathological conditions, in the MIA model, 4-ethylphenylsulfate (4EPS), indole pyruvate, serotonin, glycolate, imidazole propionate, and N-acetylserine were enormously increased in the serum of MIA offspring and entirely restored by the single B. fragilis treatment (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Hsiao, 2013, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders, Cell source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationCaspase-1-deficient mice, compared to wild-type mice, showed decreased floating time in the forced swim test, decreased anxiety-like behavior in the elevated plus-maze, decreased latency to feed in the novelty suppressed feeding test, buried fewer marbles, produced less fecal pellets, showed increased locomotion, and performed faster at the rotarod test.
“Caspase-1–deficient mice, compared to wild-type mice, showed decreased floating time in the forced swim test, decreased anxiety-like behavior as measured by the unaltered open/closed arms time ratio in the elevated plus-maze (190).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] Wong, 2016, Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition, Mol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment with minocycline or chronic restraint stress for 21 consecutive days changed the gut microbiota composition of mice compared with mice not undergoing these procedures.
“Upon treating the mice with either the minocycline antibiotic, which suppresses inflammasome activation and alters the microbiota composition, or after chronic restraint stress experiment for 21 consecutive days, the gut microbiota composition of these mice changed, compared with mice which do not undergo these procedures (190).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [190] Wong, 2016, Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition, Mol Psychiatry source
Not checked in the free run.
May combine two claims.
PremisecitationUnder physiological conditions, AIM2 inflammasome is activated during neurodevelopment and contributes to CNS physiology acting through gasdermin-D regulation, and not through IL-1β and IL-18 production.
“Under physiological conditions, AIM2 inflammasome is activated during neurodevelopment and contributes to CNS physiology acting through gasdermin-D regulation, and not through IL-1β and IL-18 production (205).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [205] Lammert, 2020, AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment, Nature source
Not checked in the free run.
May combine two claims.
Interpretationnone givenSeveral microbial factors can activate the intestinal inflammasome, which might have a distal effect on the brain.
“Several microbial factors can activate the intestinal inflammasome, which might have a distal effect on the brain.”
Quote in the paperSubstantial claim- Rests on an assumption: In the intestine under physiological conditions, resident microbes constantly stimulate inflammasomes.
May combine two claims.
PremisecitationSlrP also promotes survival of the host and microbial transmission to other hosts.
“It also promotes survival of the host, and from the microbial point of view microbial transmission to other hosts (212).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [212] Rao, 2017, Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmission, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationSeveral microbial metabolites, such as taurine, spermine, and histamine, can affect NLRP6 inflammasome activation in the gut and play an important role, if properly balanced, in host-microbial mutualism at the level of the intestine.
“Several microbial metabolites, such as taurine, spermine, and histamine, can affect the NLRP6 inflammasome activation in the gut and play an important role, if properly balanced, in host-microbial mutualism at the level of the intestine (213).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [213] Blacher, 2017, Microbiome-Modulated Metabolites at the Interface of Host Immunity, J Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationSalmonella leucine-rich repeat protein (SlrP) inhibits Salmonella virulence and the typical host anorexic response induced by the infection.
“An evidence for intestinal inflammasome activation and its effects on the brain comes from the discovery that Salmonella leucine-rich repeat protein (SlrP) inhibits Salmonella virulence and the typical host anorexic response induced by the infection (212).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [212] Rao, 2017, Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmission, Cell source
Not checked in the free run.
May combine two claims.
InterpretationreasoningEnvironmental (bacterial) factors can affect the priming of autoreactive pathogenic T cells, providing insights into pathogenic mechanisms of MS and other immune-mediated diseases.
“We therefore suggested that environmental (bacterial) factors can also affect the priming of autoreactive pathogenic T cells providing new insights into the pathogenic mechanisms of MS and other immune-mediated diseases, including neurological disorders.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
May combine two claims.
PremisecitationPriming of the pathogenic CD4+ T helper subset was dependent on ASC-dependent IL-1β production, and not on IL-12p35 or IL-12p40.
“The priming of this pathogenic subset of T helper CD4+ T cells was dependent on ASC-dependent IL-1β production, and not on IL-12p35 or IL-12p40 (132).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Ronchi, 2016, Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationAPP/PS1 mice lacking ASC, caspase-1, or NLRP3 had significantly reduced hippocampal and cortical amyloid plaque deposition and ameliorated disease outcome.
“Animal studies confirmed this significant involvement of NLRP activation, as APP/PS1 mice, lacking the expression of ASC, caspase-1, or NLRP3 had significantly reduced hippocampal and cortical amyloid plaque deposition and ameliorated disease outcome (229, 230).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationTau22 mice lacking ASC or NLRP3 expression had lower levels of aggregated and hyperphosphorylated tau in the hippocampus, and their spatial memory deficits were rescued.
“Consistent with this, Tau22 mice lacking ASC or NLRP3 expression had lower levels of aggregated and hyperphosphorylated tau in the hippocampus, and their typical spatial memory deficits were rescued (197).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197] Ising, 2019, NLRP3 inflammasome activation drives tau pathology, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationAβ accumulation activates microglia and promotes pro-inflammatory mediator production and impairment of their phagocytic function.
“Aβ accumulation activates the microglia and promotes pro-inflammatory mediators’ production and impairment of their phagocytic function (232, 233).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningInflammasome activation in AD pathogenesis could be downstream of Aβ deposit formation and could amplify neuroinflammation linked to the disease.
“All these evidences suggest that the inflammasome activation in AD pathogenesis could be downstream the Aβ deposits formation, and it could then amplify the neuroinflammation linked to the disease.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
May combine two claims.
PremisecitationInjection of caspase-1 inhibitor Ac-YVAD-CMK reduced expression of NLRP inflammasome signaling proteins and improved number of dopaminergic neurons in LPS- and 6-hydroxydopamine-induced PD in rats.
“Injection of the caspase-1 inhibitor Ac-YVAD-CMK was shown to reduce the expression of NLRP inflammasome signaling proteins and improve the number of dopaminergic neurons in LPS- and 6-hydroxydopamine-induced PD in rats (242).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [242] Mao, 2017, The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats, Neurochem Res source
Not checked in the free run.
May combine two claims.
PremisecitationIn α-synuclein A53T transgenic mouse model of PD, elevated midbrain IL-1β was measured, and lack of endogenous caspase-1 significantly reduced microglia activation.
“In the α-synuclein A53T transgenic mouse model of PD (which overexpress the mutant human A53/α-synuclein), elevated levels of IL-1β in midbrain were measured, but when the mice lack the endogenous expression of caspase-1, this significantly reduced the activation of microglia (243).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [243] Fan, 2016, MicroRNA-7 Enhances Subventricular Zone Neurogenesis by Inhibiting NLRP3/Caspase-1 Axis in Adult Neural Stem Cells, Mol Neurobiol source
Not checked in the free run.
May combine two claims.
PremisecitationFibrillar, but not monomeric, α-synuclein induced NLRP3- and caspase-1-mediated IL-1β secretion in human monocytes and BV2 microglial cell line, or via TLR-2 signaling in rodent microglial cells.
“The fibrillar, but not monomeric, form of α-synuclein induced NLRP3- and caspase-1–mediated IL-1β secretion in human monocytes and BV2 microglial cell line (238), or via TLR-2 signaling pathway in rodents microglial cells (250).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [238] Codolo, 2013, Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies, PloS One source
Not checked in the free run.
- cites [250] Kim, 2013, Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationChronic expression of IL-1β in substantia nigra of rats induced progressive death of dopaminergic neurons and motor impairments.
“Moreover, the chronic expression of IL-1β in substantia nigra of rats induced progressive death of dopaminergic neurons and resulted in motor impairments (241).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [241] Ferrari, 2006, Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra, Neurobiol Dis source
Not checked in the free run.
May combine two claims.
PremisecitationNLRP3−/− mice were resistant to loss of nigral dopaminergic neurons induced by MPTP, associated with reduction in caspase-1 activation and IL-1β and IL-18 secretion.
“Moreover, NLRP3−/− mice were resistant to the loss of nigral dopaminergic neurons induced by treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and this was associated with a reduction in caspase-1 activation and IL-1β and IL-18 secretion (244).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [244] Yan, 2015, Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIn a small cohort of MDD patients, NLRP3 mRNA and protein levels are increased in PBMCs, as are caspase-1 and IL-1β, and normalize to healthy levels upon antidepressant treatment.
“A study involving a relatively small cohort of MDD patients and healthy volunteers reported that NLRP3 mRNA and protein levels are increased in peripheral blood mononuclear cells in MDD patients, as caspase-1 and IL-1β, and normalized to healthy levels upon antidepressant treatment (245).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [245] Alcocer-Gómez, 2016, Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome, Mol Neurobiol source
Not checked in the free run.
May combine two claims.
PremisecitationPatients with SSD had higher levels of IL-18, IL-1Ra, TNF, and IL-6; OCD patients had higher levels of IL-18, IL-1Ra, and TNF, compared to healthy controls.
“In details, patients with SSD had higher levels in IL-18, IL-1Ra, TNF, and IL-6; whereas OCD patients had higher levels of IL-18, IL-1Ra, and TNF, compared to the healthy controls (248).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [248] Hylén, 2020, Increased inflammasome activity in markedly ill psychiatric patients: An explorative study, J Neuroimmunol source
Not checked in the free run.
May combine two claims.
PremisecitationThe increased inflammasome/cytokine effects in psychiatric patients were not caused by functional mutations of inflammasome components or products, BMI, age at disease onset, depression, or treatment with psychotropic drugs.
“Importantly, these effects were not caused by the presence of functional mutations of inflammasome components or products, which could lead to increased inflammasome activity and cytokine release, neither by the body mass index (BMI), age at disease onset, depression, or treatment with psychotropic drugs (248).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [248] Hylén, 2020, Increased inflammasome activity in markedly ill psychiatric patients: An explorative study, J Neuroimmunol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBHB exerts antidepressant-like effects, possibly by anti-inflammatory mechanisms that inhibit or are led by NLRP3-induced neuroinflammation in the hippocampus.
“These findings suggest that BHB exerts antidepressant-like effects, possibly by anti-inflammatory mechanisms that inhibits or are led by NLRP3-induced neuro-inflammation in the hippocampus (255).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [255] Yamanashi, 2017, Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses, Sci Rep source
Not checked in the free run.
- Rests on an assumption: Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe inflammasome is a signaling pathway that might be activated in the presence of certain bacteria and bacterial molecules.
“The inflammasome is a signaling pathway that might be activated in the presence of certain bacteria and bacterial molecules.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
A significant gap of knowledge exists in understanding the exact mechanisms involved in communication between the gut and the brain during health and disease.
“Despite growing evidence, a significant gap of knowledge still exists in understanding the exact mechanisms involved in the communication between gut and brain during health and disease.”
The paper relies on this without support.
For the majority of pathological conditions, it is not known whether dysbiosis is the cause or the consequence of the disease.
“We are at the initial phases of this discovery path, and for the majority of the pathological conditions, we still do not know if the dysbiosis is the cause or rather the consequence of it.”
The paper relies on this without support.
In AD mice, intestinal microbiota diversity is altered and SCFA levels are reduced compared to wild-type control mice.
“In addition, the intestinal microbiota diversity was altered and the levels of SCFAs were reduced in AD mice compared to wild-type control mice.”
The paper relies on this without support.
In the intestine under physiological conditions, resident microbes constantly stimulate inflammasomes.
“In the intestine, under physiological conditions, constant stimulation of inflammasomes is happening due to the resident trillions of microbes.”
The paper relies on this without support.
Findings from mouse models of AD, PD, and neuropsychiatric disorders can be generalized to human disease.
“An essential role of the microbiota in PD pathogenesis has been shown in animal models.”
The paper relies on this without support.
The composition and function of the gut microbiota in mice and humans are sufficiently similar for mouse FMT or colonization results to inform human disease mechanisms.
“GF mice colonized with microbiota from PD patients display physical impairments compared to GF mice colonized with microbiota from healthy human donors (111).”
The paper relies on this without support.
Findings from animal models and in vitro studies of neurological disease are relevant to human disease.
“Animal studies confirmed this significant involvement of NLRP activation, as APP/PS1 mice, lacking the expression of ASC, caspase-1, or NLRP3 had significantly reduced hippocampal and cortical amyloid plaque deposition and ameliorated disease outcome (229, 230).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the gut, the GM and its metabolites modulate gastrointestinal functions via effects on intestinal permeability, mucosal immune function, intestinal motility and sensitivity, and the ENS.
“In the gut, the GM and its metabolites have been shown to modulate gastrointestinal functions via their effects on intestinal permeability (32–35), mucosal immune function (36–38), intestinal motility and sensitivity (39, 40), and the enteric nervous system (ENS) (21, 24, 25, 41).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Tau22 mice are assigned two different ages for the same comparison
MinorThe table places the increase in cleaved caspase-1 and ASC at 22 months relative to 3 months, while the text places it at 11 months relative to 3 months.
“Cleaved Caspase-1, ASC↑ in the brain at the age of 22 month compared to 3 months old Tau22 wt mice.”
“Tau22 mice, another model of AD and other tauopathies, had increased levels of cleaved caspase-1 and ASC in their brain at the age of 11 months compared to their 3-month-old counterparts.”
Table assigns Ronchi et al. the wrong reference number
MinorThe EAE table cites Ronchi et al. as reference 113, but the reference list identifies 113 as Sharon et al. and 132 as Ronchi et al.
“Ronchi et al. (113)”
“113. Sharon G Cruz NJ Kang DW Gandal MJ Wang B Kim YM Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice.”
Cites
1 retracted
Kouchaki, E., Tamtaji, O. R., Salami, M., Bahmani, F., Daneshvar Kakhaki, R., Akbari, E., Tajabadi-Ebrahimi, M., Jafari, P., & Asemi, Z. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.08.015 · Cited by 317 · see citing works
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,974 · see citing works
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · see citing works
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820 · see citing works
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · see citing works
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · see citing works
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · cited 1× · see citing works
“Consistently, certain altered brain developments and behaviors observed in GF mice could be resolved/improved when new born animals were reconstituted with a diverse and intact flora (73, 82, 83).”
BackgroundHost-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · see citing works
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · see citing works
Induction of Colonic Regulatory T Cells by Indigenous <i>Clostridium</i> Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752 · see citing works
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681 · see citing works
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614 · see citing works
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works
HMDB 4.0: the human metabolome database for 2018
Wishart, D. S., Feunang, Y. D., Marcu, A., Guo, A. C., Liang, K., Vázquez-Fresno, R., Sajed, T., Johnson, D., Li, C., Karu, N., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1089 · Cited by 3,438 · see citing works
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437 · see citing works
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357 · see citing works
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283 · see citing works
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228 · see citing works
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · see citing works
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125 · see citing works
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043 · cited 1× · see citing works
“A small fraction reaches the systemic circulation and can cross the tightly regulated BBB using their own transporters located on brain vascular epithelial cells (100, 101).”
BackgroundNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · see citing works
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · see citing works
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · see citing works
The gut microbiota influences blood-brain barrier permeability in mice
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530 · see citing works
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441 · see citing works
Epidemiology of Parkinson’s disease
Tysnes, O., & Storstein, A. M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,437 · see citing works
Altered fecal microbiota composition in patients with major depressive disorder
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.016 · Cited by 2,275 · see citing works
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2014) · Cell · doi:10.1016/j.cell.2013.12.016 · Cited by 2,200 · see citing works
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198 · see citing works
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172 · see citing works
Guo, J., Huang, F., Liu, J., Chen, Y., Wang, W., Cao, B., Zou, Z., Liu, S., Pan, J., Bao, C., et al. (2016) · Scientific Reports · doi:10.1038/srep21230 · Cited by 2,148 · see citing works
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · see citing works
Peng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130 · see citing works
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024 · see citing works
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · see citing works
Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966 · see citing works
The neuroactive potential of the human gut microbiota in quality of life and depression
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0337-x · Cited by 1,963 · see citing works
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893 · see citing works
Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0307-y · Cited by 1,891 · see citing works
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · see citing works
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4611 · Cited by 1,771 · see citing works
Patra, P. P., Chikkaraddy, R., Tripathi, R. P. N., Dasgupta, A., & Kumar, G. V. P. (2014) · Nature Communications · doi:10.1038/ncomms5357 · Cited by 1,723 · see citing works
Confocal Imaging–Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
Sierra, H., Cordova, M., Chen, C.-S. J., & Rajadhyaksha, M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.371 · Cited by 1,703 · see citing works
Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559 · see citing works
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · see citing works
NLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487 · see citing works
Macia, L., Tan, J., Vieira, A. T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7734 · Cited by 1,439 · see citing works
Neufeld, K. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01620.x · Cited by 1,392 · see citing works
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386 · see citing works
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · see citing works
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307 · see citing works
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,305 · see citing works
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · see citing works
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · see citing works
Gut immune maturation depends on colonization with a host-specific microbiota
Chung, H., Pamp, S. J., Hill, J. A., Surana, N. K., Edelman, S. M., Troy, E. B., Reading, N. C., Villablanca, E. J., Wang, S., Mora, J. R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.037 · Cited by 1,241 · see citing works
The maternal microbiota drives early postnatal innate immune development
Gomez de Agüero, M., Ganal-Vonarburg, S. C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., Steinert, A., Heikenwalder, M., Hapfelmeier, S., Sauer, U., et al. (2016) · Science · doi:10.1126/science.aad2571 · Cited by 1,231 · see citing works
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182 · see citing works
Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring
Buffington, S. A., Di Prisco, G. V., Auchtung, T. A., Ajami, N. J., Petrosino, J. F., & Costa-Mattioli, M. (2016) · Cell · doi:10.1016/j.cell.2016.06.001 · Cited by 1,163 · see citing works
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159 · see citing works
Wang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., Xie, Z., Chu, X., Yang, J., Wang, H., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0216-x · Cited by 1,144 · see citing works
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,109 · see citing works
Diet, microorganisms and their metabolites, and colon cancer
O'Keefe, S. J. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.165 · Cited by 1,100 · see citing works
Gart, E., Lima, E. S., Schuren, F. H. J., de Ruiter, C., Attema, J., Verschuren, L., Keijer, J., Salic, K., Morrison, M. C., & Kleemann, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010001 · Cited by 1,098 · see citing works
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-22 · Cited by 1,076 · see citing works
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057 · see citing works
Microglial control of astrocytes in response to microbial metabolites
Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051 · see citing works
The Intestinal Microbiome in Early Life: Health and Disease
Arrieta, M.-C., Stiemsma, L. T., Amenyogbe, N., Brown, E. M., & Finlay, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00427 · Cited by 1,024 · see citing works
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014 · see citing works
Sutton, C. E., Brereton, C. F., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,009 · see citing works
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · see citing works
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., et al. (2017) · Nature · doi:10.1038/nature25158 · Cited by 983 · see citing works
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946 · see citing works
The infant microbiome development: Mom matters
Mueller, N. T., Bakacs, E., Combellick, J., Grigoryan, Z., & Dominguez-Bello, M. G. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.002 · Cited by 943 · see citing works
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933 · see citing works
Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933 · see citing works
Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.007 · Cited by 927 · see citing works
Microglia in Alzheimer's disease
Sarlus, H., & Heneka, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90606 · Cited by 911 · see citing works
Jenkins, T., Nguyen, J., Polglaze, K., & Bertrand, P. (2016) · Nutrients · doi:10.3390/nu8010056 · Cited by 904 · see citing works
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901 · see citing works
LeBlanc, J. G., Chain, F., Martín, R., Bermúdez‐Humarán, L. G., Courau, S., & Langella, P. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0691-z · Cited by 881 · see citing works
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · see citing works
Microbiota is essential for social development in the mouse
Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.65 · Cited by 866 · see citing works
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · see citing works
Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses
Geuking, M. B., Cahenzli, J., Lawson, M. A. E., Ng, D. C. K., Slack, E., Hapfelmeier, S., McCoy, K. D., & Macpherson, A. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.021 · Cited by 840 · see citing works
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137429 · Cited by 809 · see citing works
Regulation of learning and memory by meningeal immunity: a key role for IL-4
Derecki, N. C., Cardani, A. N., Yang, C. H., Quinnies, K. M., Crihfield, A., Lynch, K. R., & Kipnis, J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091419 · Cited by 800 · see citing works
Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke
Singh, V., Roth, S., Llovera, G., Sadler, R., Garzetti, D., Stecher, B., Dichgans, M., & Liesz, A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1114-16.2016 · Cited by 800 · see citing works
Baroja-Mazo, A., Martín-Sánchez, F., Gomez, A. I., Martínez, C. M., Amores-Iniesta, J., Compan, V., Barberà-Cremades, M., Yagüe, J., Ruiz-Ortiz, E., Antón, J., et al. (2014) · Nature Immunology · doi:10.1038/ni.2919 · Cited by 790 · see citing works
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · see citing works
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761 · see citing works
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 752 · see citing works
Kynurenine pathway metabolism and the microbiota-gut-brain axis
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724 · see citing works
Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau8317 · Cited by 704 · see citing works
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Kleimeyer, C., Moresi, C., Harnik, Y., Zur, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1443-5 · Cited by 700 · see citing works
Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring
Kim, S., Kim, H., Yim, Y. S., Ha, S., Atarashi, K., Tan, T. G., Longman, R. S., Honda, K., Littman, D. R., Choi, G. B., et al. (2017) · Nature · doi:10.1038/nature23910 · Cited by 678 · see citing works
Early-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652 · see citing works
Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis
Mittal, R., Debs, L. H., Patel, A. P., Nguyen, D., Patel, K. V., O’Connor, G., Grati, M., Mittal, J., Yan, D. L. S., Eshraghi, A. A., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25518 · Cited by 644 · see citing works
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
Gershon, M. D. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835bc703 · Cited by 617 · see citing works
Kim, M.-S., Kim, Y., Choi, H., Kim, W., Park, S., Lee, D., Kim, D. K., Kim, H. J., Choi, H., Hyun, D.-W., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317431 · Cited by 614 · see citing works
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595 · see citing works
Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900747 · Cited by 590 · see citing works
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies
Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works
Dempsey, C., Rubio Araiz, A., Bryson, K. J., Finucane, O., Larkin, C., Mills, E. L., Robertson, A. A. B., Cooper, M. A., O'Neill, L. A. J., & Lynch, M. A. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.014 · Cited by 571 · see citing works
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568 · see citing works
The maternal microbiome modulates fetal neurodevelopment in mice
Vuong, H. E., Pronovost, G. N., Williams, D. W., Coley, E. J. L., Siegler, E. L., Qiu, A., Kazantsev, M., Wilson, C. J., Rendon, T., & Hsiao, E. Y. (2020) · Nature · doi:10.1038/s41586-020-2745-3 · Cited by 564 · see citing works
Wang, H.-X., & Wang, Y.-P. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.190667 · Cited by 546 · see citing works
The gut microbiome in human neurological disease: A review
Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology · doi:10.1002/ana.24901 · Cited by 535 · see citing works
Cai, Y., Xue, F., Fleming, C., Yang, J., Ding, C., Ma, Y., Liu, M., Zhang, H., Zheng, J., Xiong, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11354 · Cited by 531 · see citing works
Dehay, B., Bourdenx, M., Gorry, P., Przedborski, S., Vila, M., Hunot, S., Singleton, A., Olanow, C. W., Merchant, K., Bézard, E., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00006-x · Cited by 530 · see citing works
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · see citing works
Microbiota and host determinants of behavioural phenotype in maternally separated mice
De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A. J., Green, W., Denou, E., Silva, M. A., Santacruz, A., Sanz, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8735 · Cited by 517 · see citing works
McKenzie, B., Mamik, M. K., Saito, L. B., Boghozian, R., Monaco, M. C., Major, E. O., Lu, J., Branton, W. G., & Power, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722041115 · Cited by 515 · see citing works
Ochoa-Repáraz, J., Mielcarz, D. W., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.29 · Cited by 507 · see citing works
Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502 · see citing works
A neuromodulatory role of interleukin-1β in the hippocampus
Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., & Besedovsky, H. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7778 · Cited by 498 · see citing works
Severe Food Protein-Induced Enterocolitis Syndrome to Cow’s Milk in Infants
Yang, M., Geng, L., Xu, Z., Chen, P., Friesen, C. A., Gong, S., & Li, D. (2015) · Nutrients · doi:10.3390/nu8010001 · Cited by 496 · see citing works
Fermentation in the human large intestine and the available substrates
Cummings, J. H., & Englyst, H. N. (1987) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/45.5.1243 · Cited by 490 · see citing works
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Saresella, M., La Rosa, F., Piancone, F., Zoppis, M., Marventano, I., Calabrese, E., Rainone, V., Nemni, R., Mancuso, R., & Clerici, M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0088-1 · Cited by 489 · see citing works
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487 · see citing works
NLRP3 inflammasome in neurological diseases, from functions to therapies
Song, L., Pei, L., Yao, S., Wu, Y., & Shang, Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00063 · Cited by 467 · see citing works
Role of TLR4 in the gut-brain axis in Parkinson's disease: A translational study from men to mice
Perez-Pardo, P., Dodiya, H. B., Engen, P. A., Forsyth, C. B., Huschens, A. M., Shaikh, M., Voigt, R. M., Naqib, A., Green, S. J., Kordower, J. H., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316844 · Cited by 467 · see citing works
Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids
Oldendorf, W. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.6.1450 · Cited by 463 · cited 1× · see citing works
“A small fraction reaches the systemic circulation and can cross the tightly regulated BBB using their own transporters located on brain vascular epithelial cells (100, 101).”
BackgroundAltered Gut Microbiota in a Mouse Model of Alzheimer’s Disease
Zhang, L., Wang, Y., Xiayu, X., Shi, C., Chen, W., Song, N., Fu, X., Zhou, R., Xu, Y.-F., Huang, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170020 · Cited by 449 · see citing works
Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · see citing works
Gris, D., Ye, Z., Iocca, H. A., Wen, H., Craven, R. R., Gris, P., Huang, M., Schneider, M., Miller, S. D., & Ting, J. P.-Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904145 · Cited by 429 · see citing works
The microbiota regulate neuronal function and fear extinction learning
Chu, C., Murdock, M. H., Jing, D., Won, T. H., Chung, H., Kressel, A. M., Tsaava, T., Addorisio, M. E., Putzel, G. G., Zhou, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1644-y · Cited by 421 · see citing works
Mechanisms controlling pathogen colonization of the gut
Stecher, B., & Hardt, W. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.10.003 · Cited by 415 · see citing works
Haran, J. P., Bhattarai, S. K., Foley, S. E., Dutta, P., Ward, D. V., Bucci, V., & McCormick, B. A. (2019) · mBio · doi:10.1128/mbio.00632-19 · Cited by 412 · see citing works
Gut microbiota in multiple sclerosis: possible influence of immunomodulators
Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., Venkatesan, A., Fraser, C. M., & Mowry, E. M. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000192 · Cited by 409 · see citing works
NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
Freeman, L., Guo, H., David, C. N., Brickey, W. J., Jha, S., & Ting, J. P.-Y. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20150237 · Cited by 397 · see citing works
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Barichella, M., Severgnini, M., Cilia, R., Cassani, E., Bolliri, C., Caronni, S., Ferri, V., Cancello, R., Ceccarani, C., Faierman, S., et al. (2019) · Movement Disorders · doi:10.1002/mds.27581 · Cited by 393 · see citing works
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387 · see citing works
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
Rojas, O. L., Pröbstel, A.-K., Porfilio, E. A., Wang, A. A., Charabati, M., Sun, T., Lee, D. S. W., Galicia, G., Ramaglia, V., Ward, L. A., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.035 · Cited by 382 · see citing works
(2009) · PubMed · Cited by 380 · see citing works
Multifaceted interactions between adaptive immunity and the central nervous system
Kipnis, J. (2016) · Science · doi:10.1126/science.aag2638 · Cited by 376 · see citing works
NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes
Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., & Dostert, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130624 · Cited by 369 · see citing works
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition
Pasciuto, E., Burton, O. T., Roca, C. P., Lagou, V., Rajan, W. D., Theys, T., Mancuso, R., Tito, R. Y., Kouser, L., Callaerts-Vegh, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.026 · Cited by 368 · see citing works
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001443 · Cited by 367 · see citing works
Vascular, glial, and lymphatic immune gateways of the central nervous system
Engelhardt, B., Carare, R. O., Bechmann, I., Flügel, A., Laman, J. D., & Weller, R. O. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1606-5 · Cited by 362 · see citing works
Microbiome-modulated metabolites at the interface of host immunity
Blacher, E., Levy, M., Tatirovsky, E., & Elinav, E. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601247 · Cited by 354 · see citing works
Alves de Lima, K., Rustenhoven, J., & Kipnis, J. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102319-103410 · Cited by 348 · see citing works
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
Chesselet, M.-F., Richter, F., Zhu, C., Magen, I., Watson, M. B., & Subramaniam, S. R. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0104-2 · Cited by 346 · see citing works
Immunoreactive interleukin-1β localization in the rat forebrain
Lechan, R. M., Toni, R., Clark, B. D., Cannon, J. G., Shaw, A. R., Dinarello, C. A., & Reichlin, S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90445-h · Cited by 340 · see citing works
Pokusaeva, K., Johnson, C., Luk, B., Uribe, G., Fu, Y., Oezguen, N., Matsunami, R. K., Lugo, M., Major, A., Mori‐Akiyama, Y., et al. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.12904 · Cited by 337 · see citing works
Uchiyama, Y., Nakashima, M., Watanabe, S., et al. (2017) · Scientific Reports · doi:10.1038/srep39897 · Cited by 337 · see citing works
Gomez, F. A., Lee, S., Hernandez, F. J., Chiaverano, L. M., Muller-Karger, F. E., Liu, Y., & Lamkin, J. T. (2019) · Scientific Reports · doi:10.1038/s41598-018-36655-y · Cited by 337 · see citing works
Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory
Ribeiro, M., Brigas, H. C., Temido-Ferreira, M., Pousinha, P. A., Regen, T., Santa, C., Coelho, J. E., Marques-Morgado, I., Valente, C. A., Omenetti, S., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aay5199 · Cited by 335 · see citing works
Greninger, A. L., Messacar, K., Dunnebacke, T. H., Naccache, S. N., Federman, S., Bouquet, J., Mirsky, D. M., Nomura, Y., Yagi, S., Glaser, C. A., et al. (2016) · Genome Medicine · doi:10.1186/s13073-015-0257-9 · Cited by 333 · see citing works
Sassone‐Corsi, M., & Raffatellu, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403169 · Cited by 330 · see citing works
Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis
Baj, A., Moro, E., Bistoletti, M., Orlandi, V. T., Crema, F., & Giaroni, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061482 · Cited by 330 · see citing works
[Epidemiology of Parkinson disease].
Domínguez Carmona, M. (1989) · PubMed · Cited by 329 · see citing works
Nitric Oxide Synthase Expression in Bone Cells
Fox, S. W., & Chow, J. W. M. (1998) · Bone · doi:10.1016/s8756-3282(98)00070-2 · Cited by 320 · see citing works
Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model
Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., & Endres, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160926 · Cited by 318 · see citing works
C9orf72 suppresses systemic and neural inflammation induced by gut bacteria
Burberry, A., Wells, M. F., Limone, F., Couto, A., Smith, K. S., Keaney, J., Gillet, G., van Gastel, N., Wang, J.-Y., Pietilainen, O., et al. (2020) · Nature · doi:10.1038/s41586-020-2288-7 · Cited by 314 · see citing works
Novel insights into the development and maintenance of the blood-brain barrier
Engelhardt, B., & Liebner, S. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1811-2 · Cited by 313 · see citing works
Kaushal, V, Dye, R., Pakavathkumar, P., Foveau, B., Flores, J., Hyman, B., Ghetti, B., Koller, B. H., & LeBlanc, A. C. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.16 · Cited by 297 · see citing works
Inhibition of autoimmune encephalomyelitis by a tetracycline
Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D. (2002) · Annals of Neurology · doi:10.1002/ana.10092 · Cited by 295 · see citing works
Nankova, B. B., Agarwal, R., MacFabe, D. F., & La Gamma, E. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103740 · Cited by 294 · see citing works
Gong, Z., Pan, J., Shen, Q., Li, M., & Peng, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1282-6 · Cited by 289 · see citing works
A gut microbial factor modulates locomotor behaviour in Drosophila
Schretter, C. E., Vielmetter, J., Bartos, I., Marka, Z., Marka, S., Argade, S., & Mazmanian, S. K. (2018) · Nature · doi:10.1038/s41586-018-0634-9 · Cited by 289 · see citing works
Bile acid signaling pathways from the enterohepatic circulation to the central nervous system
Mertens, K. L., Kalsbeek, A., Soeters, M. R., & Eggink, H. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00617 · Cited by 287 · see citing works
Durrenberger, P. F., Ettorre, A., Kamel, F. O., Webb, L. V., Sim, M. J. W., Nicholas, R. S., Malik, O., Reynolds, R., Boyton, R. J., & Altmann, D. M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-1 · Cited by 286 · see citing works
Sheng, J. G., Ito, K., Skinner, R. D., Mrak, R. E., Rovnaghi, C. R., van Eldik, L. J., & Griffin, W. S. T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00104-2 · Cited by 269 · see citing works
Probiotic Supplementation in Patients with Alzheimer’s Dementia - An Explorative Intervention Study
Leblhuber, F., Steiner, K., Schuetz, B., Fuchs, D., & Gostner, J. M. (2018) · Current Alzheimer Research · doi:10.2174/1389200219666180813144834 · Cited by 269 · see citing works
Gut microorganisms act together to exacerbate inflammation in spinal cords
Miyauchi, E., Kim, S.-W., Suda, W., Kawasumi, M., Onawa, S., Taguchi-Atarashi, N., Morita, H., Taylor, T. D., Hattori, M., & Ohno, H. (2020) · Nature · doi:10.1038/s41586-020-2634-9 · Cited by 268 · see citing works
Mortality in patients with multiple sclerosis
Scalfari, A., Knappertz, V. A., Cutter, G., Goodin, D. S., Ashton, R., & Ebers, G. C. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a3388 · Cited by 261 · see citing works
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Gil-Cruz, C., Perez-Shibayama, C., De Martin, A., Ronchi, F., van der Borght, K., Niederer, R., Onder, L., Lütge, M., Novkovic, M., Nindl, V., et al. (2019) · Science · doi:10.1126/science.aav3487 · Cited by 260 · see citing works
Self-citationKieper, W. C., Troy, A., Burghardt, J. T., Ramsey, C., Lee, J. Y., Jiang, H.-Q., Dummer, W., Shen, H., Cebra, J. J., & Surh, C. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3158 · Cited by 250 · see citing works
Santos, S. S., Santos, S., Pinto, A. R. T., Ramu, V. G., Heras, M., Bardajı́, E., Tavares, I., & Castanho, M. A. R. B. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00001 · Cited by 250 · see citing works
A 3D human brain–like tissue model of herpes-induced Alzheimer’s disease
Cairns, D. M., Rouleau, N., Parker, R. N., Walsh, K. G., Gehrke, L., & Kaplan, D. L. (2020) · Science Advances · doi:10.1126/sciadv.aay8828 · Cited by 247 · see citing works
Pro-cognitive properties of T cells
Kipnis, J., Gadani, S., & Derecki, N. C. (2012) · Nature Reviews Immunology · doi:10.1038/nri3280 · Cited by 246 · see citing works
Ferrari, C. C., Pott Godoy, M. C., Tarelli, R., Chertoff, M., Depino, A. M., & Pitossi, F. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.013 · Cited by 235 · see citing works
Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients
Ojala, J., Alafuzoff, I., Herukka, S.-K., van Groen, T., Tanila, H., & Pirttilä, T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.006 · Cited by 235 · see citing works
Stecher, B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0008-2014 · Cited by 235 · see citing works
The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173032 · Cited by 230 · see citing works
Butyrate suppresses demyelination and enhances remyelination
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229 · see citing works
A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
Voet, S., Mc Guire, C., Hagemeyer, N., Martens, A., Schroeder, A., Wieghofer, P., Daems, C., Staszewski, O., Vande Walle, L., Jordao, M. J. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04376-5 · Cited by 227 · see citing works
The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders
Hughes, H. K., Rose, D., & Ashwood, P. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0887-6 · Cited by 225 · see citing works
AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment
Lammert, C. R., Frost, E. L., Bellinger, C. E., Bolte, A. C., McKee, C. A., Hurt, M. E., Paysour, M. J., Ennerfelt, H. E., & Lukens, J. R. (2020) · Nature · doi:10.1038/s41586-020-2174-3 · Cited by 223 · see citing works
Serotonin stimulates secretion of exosomes from microglia cells
Glebov, K., Löchner, M., Jabs, R., Lau, T., Merkel, O., Schloss, P., Steinhäuser, C., & Walter, J. (2015) · Glia · doi:10.1002/glia.22772 · Cited by 221 · see citing works
Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders
Fleshner, M., Frank, M., & Maier, S. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.125 · Cited by 216 · see citing works
Alcocer-Gómez, E., Casas-Barquero, N., Williams, M. R., Romero-Guillena, S. L., Cañadas-Lozano, D., Bullón, P., Sánchez-Alcazar, J. A., Navarro-Pando, J. M., & Cordero, M. D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.028 · Cited by 215 · see citing works
Yamanashi, T., Iwata, M., Kamiya, N., Tsunetomi, K., Kajitani, N., Wada, N., Iitsuka, T., Yamauchi, T., Miura, A., Pu, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08055-1 · Cited by 214 · see citing works
Kwon, H.-K., Kim, G.-C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.-E., Nam, J. H., & Im, S.-H. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.001 · Cited by 212 · see citing works
Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle?
O’Mahony, S. M., Clarke, G., Dinan, T. G., & Cryan, J. F. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.068 · Cited by 203 · see citing works
Host microbiota modulates development of social preference in mice
Arentsen, T., Raith, H., Qian, Y., Forssberg, H., & Heijtz, R. D. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.29719 · Cited by 202 · see citing works
Determinants of Human B Cell Migration Across Brain Endothelial Cells
Alter, A., Duddy, M., Hebert, S., Biernacki, K., Prat, A., Antel, J. P., Yong, V. W., Nuttall, R. K., Pennington, C. J., Edwards, D. R., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4497 · Cited by 195 · see citing works
Barrientos, R. M., Sprunger, D. B., Campeau, S., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.009 · Cited by 192 · see citing works
Gastrointestinal inflammation by gut microbiota disturbance induces memory impairment in mice
Jang, S.-E., Lim, S.-M., Jeong, J.-J., Jang, H.-M., Lee, H.-J., Han, M. J., & Kim, D.-H. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.49 · Cited by 190 · see citing works
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment
Halaby, M. J., Hezaveh, K., Lamorte, S., Ciudad, M. T., Kloetgen, A., MacLeod, B. L., Guo, M., Chakravarthy, A., Medina, T. D. S., Ugel, S., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aax8189 · Cited by 188 · see citing works
Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment
Singhal, G., Jaehne, E. J., Corrigan, F., & Baune, B. T. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00097 · Cited by 186 · see citing works
Belluzzi, E., Gonnelli, A., Cirnaru, M., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0066-z · Cited by 186 · see citing works
Msambichaka, B., Eze, I. C., Abdul, R., Abdulla, S., Klatser, P. R., Tanner, M., Kaushik, R., Geubbels, E. L. P. E., & Probst-Hensch, N. M. (2018) · Nutrients · doi:10.3390/nu10020222 · Cited by 186 · see citing works
Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition
Mamantopoulos, M., Ronchi, F., Van Hauwermeiren, F., Vieira-Silva, S., Yilmaz, B., Martens, L., Saeys, Y., Drexler, S. K., Yazdi, A. S., Raes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.011 · Cited by 181 · see citing works
Jia, L., Li, D., Feng, N., Shamoon, M., Sun, Z., Ding, L., Zhang, H., Chen, W., Sun, J., & Chen, Y. Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-07335-0 · Cited by 179 · see citing works
Microbiota-gut brain axis involvement in neuropsychiatric disorders
Iannone, L. F., Preda, A., Blottière, H. M., Clarke, G., Albani, D., Belcastro, V., Carotenuto, M., Cattaneo, A., Citraro, R., Ferraris, C., et al. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1638763 · Cited by 177 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432 · see citing works
Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415 · see citing works
Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094494 · Cited by 202 · see citing works
Barrio, C., Arias-Sánchez, S., & Martín-Monzón, I. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105640 · Cited by 143 · see citing works
Zhao, N., Chen, Q.-G., Chen, X., Liu, X.-T., Geng, F., Zhu, M.-M., Yan, F.-L., Zhang, Z.-J., & Ren, Q.-G. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.11.013 · Cited by 105 · see citing works
Knox, E. G., Aburto, M. R., Tessier, C., Nagpal, J., Clarke, G., O’Driscoll, C. M., & Cryan, J. F. (2022) · iScience · doi:10.1016/j.isci.2022.105648 · Cited by 97 · see citing works
Song, L., Sun, Q., Zheng, H., Zhang, Y., Wang, Y., Liu, S., & Duan, L. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200164 · Cited by 91 · see citing works
Benameur, T., Porro, C., Twfieg, M.-E., Benameur, N., Panaro, M. A., Filannino, F. M., & Hasan, A. (2023) · Brain Sciences · doi:10.3390/brainsci13081226 · Cited by 60 · see citing works
Hurkacz, M., Dobrek, L., & Wiela-Hojeńska, A. (2021) · Molecules · doi:10.3390/molecules26247456 · Cited by 60 · see citing works
Yeo-Teh, N. S. L., & Tang, B. L. (2023) · Science and Engineering Ethics · doi:10.1007/s11948-022-00422-0 · Cited by 28 · see citing works
Jia, X., Chen, Q., Zhang, Y., & Asakawa, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296713 · Cited by 22 · see citing works
Gut microbiota in multiple sclerosis and animal models
Schumacher, S. M., Doyle, W. J., Hill, K., & Ochoa‐Repáraz, J. (2025) · The FEBS Journal · doi:10.1111/febs.17161 · Cited by 21 · see citing works
Analysis of gut microbiota and depression and anxiety: Mendelian randomization from three datasets
Lai, Y., & Xiong, P. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.03.012 · Cited by 20 · see citing works
Karbownik, M. S., Sokołowska, P., & Kowalczyk, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076617 · Cited by 6 · see citing works
The role of teichoic acids of bifidobacteria in driving the interaction with the human host
Longhi, G., Vergna, L. M., Lugli, G. A., Bianchi, M. G., Tarracchini, C., Milani, C., Turroni, F., Bussolati, O., van Sinderen, D., & Ventura, M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1616397 · Cited by 6 · see citing works
Chehadi, A. C., Pereira de Lima, E., Detregiachi, C. R. P., Santos de Argollo Haber, R., Catharin, V. M. C. S., Fornari Laurindo, L., Engracia Valenti, V., Machado Galhardi, C., Tanaka, M., & Maria Barbalho, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010465 · Cited by 8 · see citing works
- Authors
- Rutsch, A., Kantsjö, J. B., & Ronchi, F.
- Affiliations
- University of Bern (CH)
- Corresponding author
- Ronchi, Francesca
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-10
- Volume
- 11
- Pages
- 604179-604179
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7758428
- OpenAlex
- W3111897458
- Semantic Scholar
- 29a07f4cb9063457f53723c6a4328c6b5202423e
- Cited by
- 821
- References
- 288
- Citations by year
- 2026: 111 · 2025: 196 · 2024: 188 · 2023: 168 · 2022: 120 · 2021: 37 · 2020: 1
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open Access CRIS of the University of Bern
- Funders
- Novartis Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- gut-brain axis, gut microbiota, dysbiosis, inflammasome, neuroinflammation, blood-brain barrier permeability, vagus nerve, bacterial metabolites, IL-1β, IL-18, pyroptosis, multiple sclerosis, Alzheimer's disease, Parkinson's disease, neuropsychiatric disorders, anxiety, depression, brain development
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Mental Disorders, Brain, Brain Diseases, Humans, Intestines, Host-Pathogen Interactions, Inflammasomes, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review